fluorescein has been researched along with Dry Eye in 361 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.28) | 18.7374 |
| 1990's | 20 (5.54) | 18.2507 |
| 2000's | 81 (22.44) | 29.6817 |
| 2010's | 162 (44.88) | 24.3611 |
| 2020's | 97 (26.87) | 2.80 |
| Authors | Studies |
|---|---|
| Boehmer, BE; Ciolino, JB; Krösser, S; McLaurin, E; Meides, AS; Ousler, GW; Schlüter, T; Sheppard, JD; Usner, D; Wirta, DL | 1 |
| Adanusa, M; Akorsah, B; Ali-Baya, SK; Animful, S; Asiedu, K; Ephraim, RKD; Kyei, S; Sekyere, MA | 1 |
| Lee, J; Mecum, NE; Meng, ID; Russell, R; Sullivan, C | 1 |
| Diz-Arias, E; Fernández-Jimenez, E; Peral, A | 1 |
| Fan, F; Jin, X; Mou, Y; Shen, X; Wang, C; Wang, X; Wu, Y; Yuan, K | 1 |
| Juo, SH; Liang, CL; Liao, CH; Lin, SL; Tseng, CL | 1 |
| Le, Q; Zhao, S | 1 |
| Chouhan, JK; Jain, N; Sharma, P | 1 |
| Chen, S; Chen, X; Cheng, J; Cong, L; Dong, Y; Lee, M; Li, D; Ousler, GW; Qu, X; Wang, H; Wang, M; Wang, S; Xie, L; Yang, N; Zhang, T; Zhou, X | 1 |
| Chang, YA; Hu, FR; Hung, KF; Li, TY; Sun, YC; Yeh, PT | 1 |
| Aoki, T; Deguchi, H; Nagata, K; Sekiyama, Y; Sotozono, C; Yokoi, N | 1 |
| Baiza-Durán, L; Correa-Gallegos, EY; Medina-Espinoza, JM; Muñoz-Villegas, P; Navarro-Sanchez, AA; Olvera-Montaño, O; Sánchez-Ríos, A | 1 |
| Chen, L; Gong, Q; Hu, L; Lu, F; Ren, W; Wang, Y; Xu, Z | 1 |
| Bayraktar Bilen, N; Bilen, Ş; Evren Kemer, Ö; Topçu Yılmaz, P | 1 |
| Geerling, G; Kourukmas, R; Roth, M | 1 |
| Latif, N; Naroo, SA | 1 |
| Fan, X; Jin, X; Min, J; Mou, Y; Wang, X; Wu, Y | 1 |
| Baillif, S; Calonge, M; Cochener, B; Gain, P; Mearza, A; Paw, E; Sahyoun, M | 1 |
| Sang Min, J; Shin, D | 1 |
| Ayaki, M; Miyasaka, K; Negishi, K | 1 |
| Chauhan, SK; Cho, W; Gong, L; Guan, Y; Li, B; Pan, L; Wu, M; Yang, Z; Zeng, W | 1 |
| Begley, CG; Caffery, B; Nelson, JD; Situ, P | 1 |
| Aghamollaei, H; Bagheri, M; Daryabari, SH; Dehpour, AR; Noori, T; Sheibani, M; Shirooie, S; Tavangar, SM; Yousefi-Manesh, H | 1 |
| Hori, Y; Inai, M; Oka, K | 1 |
| Begley, C; Braun, RJ; King-Smith, PE | 1 |
| Liu, XN; Xu, K; Zhang, HB; Zhang, XJ; Zhu, XP | 1 |
| Dana, R; Dohlman, TH; Musayeva, A; Singh, RB; Sinha, S; Taketani, Y; Wang, S; Yuksel, E | 1 |
| Allam, IY; Doheim, MF; Lazreg, S; Mohammed, MA; Shaheen, MS | 1 |
| Jerkins, G; Nau, J; Pattar, GR; Striffler, K; Torkildsen, GL | 1 |
| Jia, Y; Miao, S; Pan, Z; Yan, R | 1 |
| Ferrová, K; Fík, Z; Helisová, K; Mahelková, G; Minaříková, M; Štorm, J | 1 |
| Alves, M; Aranha, FJP; Colella, MP; de Almeida Borges, D; Fernandes, A; Fornazari, DO; Pozzebon, ME; Rodrigues, M; Trindade, M; Vigorito, AC | 1 |
| Jiang, X; Jie, Y; Jin, X; Li, X; Peng, W; Wu, M; You, Z; Zhou, Q; Zhou, S; Zhu, L | 1 |
| Birangal, S; Chaudhari, P; Ghate, V; Kodoth, AK; Lewis, SA; Mallela, LS; Mavlankar, N; Nampoothiri, M; Pal, A; Roy, S | 1 |
| Farrahi, F; Jahani, S; Mobarez, F; Savaie, M; Sayadi, N; Sharhani, A | 1 |
| Chen, Y; Gao, M; Gao, R; Wu, Y; Zhang, K | 1 |
| Feng, J; He, Y; Kang, H; Liu, Y; Peng, Y; Ren, Y; Shi, W; Tan, Y; Wu, M; Wu, R; Zhang, G | 1 |
| Ashok, A; Chang, K; Chen, DF; Cho, KS; Dartt, DA; Lee, C; Lennikov, A; Utheim, TP; Yang, M | 1 |
| Hu, Q; Jiang, B; Li, C; Li, T; She, M; Zhou, X | 1 |
| Lei, Y; Liu, J; Peng, J; Zhong, J | 1 |
| Hori, Y; Itokawa, T; Koh, S; Suzuki, T | 1 |
| Berdy, GJ; Krösser, S; Tauber, J; Vittitow, JL; Wirta, DL | 1 |
| Evans, D; Li, XY; Lu, C; Novack, GD; Segal, B; Shen, W; Tauber, J | 1 |
| Ding, Y; Li, ZZ; Su, JZ; Yu, GY; Zeng, WZ; Zhu, H; Zou, YP | 1 |
| Hori, Y; Itokawa, T; Iwashita, H; Koji, K; Okajima, Y; Suzuki, T | 1 |
| Aranha Dos Santos, V; Bagherinia, H; Fard, A; Garhöfer, G; Schmetterer, L; Schmidl, D; Stegmann, H; Werkmeister, RM | 1 |
| Kikukawa, Y; Kosugi, T; Pflugfelder, SC; Tanaka, S | 1 |
| Dai, H; Gao, Z; Gu, H; Jie, Y; Jin, X; Ke, B; Krösser, S; Ma, K; Ma, L; Pei, C; Shi, X; Tian, L; Wang, L; Xu, G; Xu, Y; Zhang, H; Zhang, Y; Zhao, S; Zhu, L | 1 |
| Epitropoulos, AT; Krösser, S; Kurata, F; Sheppard, JD; Vittitow, JL | 1 |
| Furusawa, Y; Kato, H; Kusada, N; Sakai, R; Sotozono, C; Yokoi, N | 1 |
| Akpek, EK; Ciolino, JB; Downing, JE; Krösser, S; Meides, AS; Sheppard, JD; Tauber, J; Wirta, DL | 1 |
| Rao, SK; Srinivas, SP | 1 |
| Ganesh, S; Gaur, A; Gupta, S; Rahman, M; Sangwan, VS; Tibrewal, S | 1 |
| Arvind, A; Bhuvana, K; Kamath, V | 1 |
| Garkal, P; Shukla, AK; Singh, S; Yadav, V | 1 |
| Jain, P; Soni, M; Walia, S | 1 |
| Jain, K; Jaju, M; Yadav, D | 1 |
| Çankaya, AB; Dikmetaş, Ö; İrkeç, M; Kocabeyoğlu, S; Özturan, İ; Tellioğlu, HT | 1 |
| Özcan, G; Uçakhan, ÖÖ | 1 |
| de Paiva, CS; Pflugfelder, SC; Yoon, SP; Yu, Z | 1 |
| Casemore, RK; Dutta, D; Wolffsohn, JS | 1 |
| Kokkinakis, J; Millar, TJ; Schuett, BS | 1 |
| Barbosa, I; Castro, C; Ferreira, A; José, D; Marques, JH; Marta, A; Menéres, MJ; Neves, I; Sousa, P | 1 |
| Bhargava, R; Pandey, K; Rajpoot, M; Singh, D | 1 |
| Fu, J; Jia, Q; Zhao, X | 1 |
| Gao, WP; Jie, RP; Liu, CY; Liu, X; Zhao, N | 1 |
| Chen, E; De Jesus, MT; Farid, M; Garg, S; Jester, JV; Kwan, J; Nguyen, AL; Nguyen, T; Paugh, JR; Sasai, A; Tse, J | 1 |
| Dogru, M; Fujishima, H; Kozuki, N; Shibasaki, A; Yazu, H | 1 |
| Wang, S; Zhang, H | 1 |
| Adhikari, N; Bang, SP; Jun, JH; Kim, H; Kim, JY; Lee, DC; Lee, HG; Neupane, S; Son, MJ; Yeon, CY | 1 |
| Gomi, F; Hosotani, Y; Ishikawa, H; Kato, H; Komuro, A; Mimura, O; Okamoto, M; Yokoi, N | 1 |
| Kim, SE; Yang, HJ; Yang, SW | 1 |
| Jia, T; Liao, R; Stapleton, F; Tan, J | 1 |
| Barbosa, F; Garcia, DM; Pereira, LA; Pontelli, RCN; Rocha, BA; Rocha, EM; Souza, MCO | 1 |
| Anwar, A; Bandlitz, S; Bikhu, P; Jaeger, K; Nosch, DS; Peter, B; Pflugi, T; Wolffsohn, JS | 1 |
| Huntjens, B; Mulder, JA; van Tilborg, MM | 1 |
| Cox, SM; Nichols, KK; Osei, KA | 1 |
| Chang, SW; Su, TY | 1 |
| Allen, PM; Briggs, N; Lievens, CW; Norgett, Y; Vianya-Estopa, M | 1 |
| Awisi-Gyau, D; Begley, CG; Braun, RJ; Driscoll, TA; Luke, RA | 1 |
| Choi, KR; Han, KE; Jun, RM; Lee, SM | 1 |
| Galor, A; Hackam, AS; Huang, A; Janecki, J; Jeng, BH; Kumar, N; Menendez, D; Rock, S | 1 |
| Bernabei, F; Del Noce, C; Giannaccare, G; Pellegrini, M; Scotto, R; Senni, C; Traverso, CE; Vagge, A | 1 |
| Choi, H; Jang, G; Jeong, GY; Kang, WS; Kim, E; Kim, JS; Kim, KJ; Kim, S; Lee, KH; Na, CS | 1 |
| Chen, H; Fan, Y; Feng, X; Niu, G | 1 |
| Hsiao, CH; Hwang, YS; Lee, CY; Michihito, I; Sun, CC; Tagami, K | 1 |
| Banafshe Afshan, A; Ghaffari, R; Ghassemi, H; Houshang Beheshtnejad, A; Kheirkhah, A; Latifi, G; Mohammadi, N; Mohammadi, SS; Zarei-Ghanavati, M | 1 |
| Hwang, HB; Hwang, HS; Kim, EC; Kim, HS; Kim, MS; Ku, YH | 1 |
| Ayaki, M; Negishi, K; Takei, K; Tsubota, K; Uchino, M | 1 |
| Krösser, S; Majmudar, PA; Sall, K; Tauber, J; Willen, D; Wirta, DL | 1 |
| Brady, TC; Clark, D; Sheppard, J; Tauber, J | 1 |
| Garcia-Queiruga, J; Garcia-Resua, C; Giraldez, MJ; Pena-Verdeal, H; Yebra-Pimentel, E | 1 |
| Keren, S; Levinger, E; McCallum, E; Mimouni, M; Rabina, G | 1 |
| Ali, A; Elbaz, U; Fung, SSM; Mireskandari, K; Ong Tone, S | 1 |
| Jin, X; Lin, L; Min, J; Mou, Y; Wang, X; Wu, Y; Xiang, H; Yuan, K | 1 |
| Akpek, E; Eberhart, CG; Liu, T; Siadati, S | 1 |
| Lin, F; Liu, H; Ma, L; Mao, X | 1 |
| Ekın, MA; Imre, SS; Kahraman, HG; Ugurlu, SK | 1 |
| Deep Singh Talwar, G; He, W; He, X; Moore, JE; Pazo, EE; Qin, G; Song, Y; Wu, Y; Xu, L; Yang, L; Yu, S; Zhang, Q | 1 |
| Chen, H; Gao, C; Jin, Y; Li, Y; Liu, R; Qi, H | 1 |
| Garaszczuk, IK; Iskander, DR | 1 |
| Hanada, K; Kawahara, A; Utsunomiya, T; Yoshida, A | 1 |
| Georgiev, GA; Kato, H; Kinoshita, S; Komuro, A; Sonomura, Y; Sotozono, C; Tsubota, K; Yokoi, N | 1 |
| Aragona, E; Aragona, P; Cannavò, SP; Giuffrida, R; Interdonato, A; Postorino, EI; Puzzolo, D; Rania, L | 1 |
| Amparo, F; Dana, R; Marmalidou, A; Wang, H; Yin, J | 1 |
| Amrane, M; Baudouin, C; de la Maza, MS; Figueiredo, FC; Garrigue, JS; Ismail, D; Leonardi, A | 1 |
| Arita, R; Chalmers, R; Craig, JP; Djalilian, A; Dogru, M; Dumbleton, K; Gupta, PK; Jones, L; Karpecki, P; Lazreg, S; Pult, H; Sullivan, BD; Tomlinson, A; Tong, L; Villani, E; Wolffsohn, JS; Yoon, KC | 1 |
| Chen, WL; Hu, FR; Liou, HM; Sun, YC; Yeh, PT | 1 |
| Bartuzel, MM; Cervino Exposito, A; Garaszczuk, IK; Iskander, DR; Montes-Micó, R; Mousavi, M | 1 |
| Korshunova, GA; Shishkina, AV; Skulachev, MV | 1 |
| Acar, N; Alassane, S; Arnould, L; Binquet, C; Bretillon, L; Bron, AM; Creuzot-Garcher, C; Delcourt, C; Ferrero, A; Muselier-Mathieu, A | 1 |
| Braun, RJ; Henshaw, WD; King-Smith, PE; Li, L | 1 |
| Chiambaretta, F; Courrier, E; Gain, P; Garcin, T; Garhofer, G; Kaspi, M; Lambert, V; Marcon, A; Renault, D; Thuret, G | 1 |
| Dursch, TJ; Li, W; Lin, MC; Radke, CJ; Taraz, B | 1 |
| Aydin, R; Balevi, A; Erdur, SK; Kocabora, MS; Ozsutcu, M | 1 |
| Bunya, VY; Fernandez, KB; Hammersmith, KM; Macchi, I; Massaro-Giordano, M; Nagra, PK; Orlin, SE; Rapuano, CJ; Sulewski, ME; Ying, GS | 1 |
| Craig, JP; Wang, MTM | 1 |
| Dana, R; Dohlman, T; Kheirkhah, A; Saboo, U; Yin, J | 1 |
| Beylerian, H; Beylerian, M; Darque, A; Grimaud, F; Hoffart, L; Lazaro, M; Magalon, J; Sabatier, F; Stolowy, N; Veran, J | 1 |
| Afshari, N; Freeman, WR; Gaber, R; Gomez, ML; Meshi, A; Muftuoglu, IK; Uwe, DB; You, Q | 1 |
| He, J; Lu, L; Xu, Y; Zhang, B; Zhu, J; Zou, H; Zou, X | 1 |
| Amparo, F; Dana, R; Saboo, U; Shikari, H | 1 |
| Abengózar-Vela, A; Calonge, M; Enríquez-de-Salamanca, A; González-García, MJ; Schaumburg, CS; Stern, ME | 1 |
| Bağbaba, A; Delen, D; Şen, B; Uysal, BS | 1 |
| Begley, CG; Braun, RJ; King-Smith, PE; Zhong, L | 1 |
| Craig, JP; Dean, SJ; Wang, MTM; Xue, AL | 1 |
| Baudouin, C; Labbé, A; Liang, Q; Su, G; Su, Y; Wang, N | 1 |
| Tsubota, K | 1 |
| Han, J; Liu, X; Shao, T; Wang, Y; Wu, M | 1 |
| Andrinolo, D; Colman Lerner, JE; Giuliani, DS; Gutierrez, MLA; Porta, AA | 1 |
| Barabino, S; Baudouin, C; Daull, P; Docquier, M; Feraille, L; Garrigue, JS; Kessal, K; Parsadaniantz, SM | 1 |
| Bernabei, F; Campos, EC; Giannaccare, G; Pellegrini, M; Roda, M; Sebastiani, S; Taroni, L; Versura, P | 1 |
| Ciepiaszuk, K; Huc, T; Skrzypecki, J; Ufnal, M | 1 |
| Beckert, M; Ciolino, JB; Jentsch, G; Krösser, S; Lonsdale, JD; Moreira, HR; Ousler, GW; Steven, P; Torkildsen, GL; Wirta, DL | 1 |
| Dogru, M; Kojima, T; Shimizu, T; Shinzawa, M; Tsubota, K | 1 |
| Hou, L; Jiang, J; Lu, F; Shen, M; Zhang, B; Zhuo, R | 1 |
| Ali, A; Elbaz, U; Levy, D; Mireskandari, K; Ong Tone, S; Silverman, E; Williams, S | 1 |
| Chan, JK; Lam, AK; Ng, RW; Tai, SK | 1 |
| Choi, YH; Kim, DH; Kim, MK; Kim, Y; Paik, HJ | 1 |
| Hutchings, N; Jones, L; Srinivasan, S; Woods, J | 1 |
| Craig, JP; Feng, J; Turnbull, PR; Wang, MTM; Wong, J | 1 |
| Hoehn, AL; Leonard, BC; Murphy, CJ; Shaw, GC; Stanley, AA; Stewart, KA; Thomasy, SM | 1 |
| Cao, L; Cyr, D; Demers, D; Malon, J; Mecum, NE; Meng, ID | 1 |
| Boldin, I; Horwath-Winter, J; Klein, A; Rabensteiner, DF | 1 |
| Itoh, S; Kagawa, Y; Shinohara, H | 1 |
| Alex, A; de Paiva, CS; Edwards, A; Hays, JD; Kerkstra, M; Pflugfelder, SC; Shih, A | 1 |
| Amparo, F; Dana, R; Dastjerdi, MH; Ferrari, G; Hamrah, P; Jurkunas, U; Okanobo, A; Schaumberg, DA; Smaga, L | 1 |
| Ikeda, C; Koh, S; Maeda, N; Nishida, K; Takai, Y; Watanabe, H | 1 |
| Ge, L; Gong, L; Hong, J; Le, Q; Li, M; Wu, L; Xu, J | 1 |
| Emamian, MH; Fotouhi, A; Hashemi, H; Khabazkhoob, M; Kheirkhah, A; Mehravaran, S; Shariati, M | 1 |
| Amparo, F; Dana, R; Hamrah, P; Jin, Y; Schaumberg, DA | 1 |
| Deng, X; Gao, Y; He, M; Li, N; Zhang, S; Zhao, D | 1 |
| Murube, J | 1 |
| He, L; Li, M; Li, T; Shen, Y; Xu, H; Yu, Y; Zhao, J; Zhou, X | 1 |
| Dogru, M; Ibrahim, OM; Kojima, T; Matsumoto, Y; Tsubota, K; Wakamatsu, TH | 1 |
| Downie, LE; Keller, PR; Vingrys, AJ | 1 |
| Foulks, GN; Lemp, MA; Pepose, JS; Sullivan, BD | 1 |
| Fenner, BJ; Tong, L | 1 |
| Awamura, S; Kinoshita, S; Nakamichi, N; Oshiden, K; Suzuki, H; Yokoi, N | 2 |
| Huang, R; Li, K; Li, Q; Lu, R; Quan, Y; Yang, H; Zhang, X | 1 |
| D'Ambrosio, FA; Eiferman, RA; Kennedy, KS; Lonsdale, JD; McLaurin, EB; Semba, CP; Sheppard, JD; Torkildsen, GL | 1 |
| Calonge, M; Enríquez-de-Salamanca, A; Fernández, I; García, N; González-García, MJ; Mena, L; Sacristán, A; Tesón, M | 1 |
| Calonge, M; Enríquez-de-Salamanca, A; González-García, MJ; López-Miguel, A; Martín-Montañez, V; Stern, ME; Tesón, M | 1 |
| Barreira, N; García-Resúa, C; Mosquera, A; Penedo, MG; Ramos, L; Yebra-Pimentel, E | 1 |
| Park, IK; Sook Chun, Y | 1 |
| Celebi, AR; Mirza, GE; Ulusoy, C | 1 |
| Lee, BT; Liu, C; Lu, W; Wang, Y; Wei, G; Zhang, W | 1 |
| Jie, Y; Labbe, A; Pan, Z; Qin, Y; Tan, X; Zhang, Y | 1 |
| Amparo, F; Dana, R; Hamrah, P; Schaumberg, DA | 1 |
| Doughty, MJ | 1 |
| Bandello, F; Berchicci, L; Iuliano, L; Miserocchi, E; Modorati, G | 1 |
| Hwang, HS; Kim, EC; Lee, WS; Sung, YM | 1 |
| Amrane, M; Baudouin, C; Creuzot-Garcher, C; Garrigue, JS; Ismail, D; Pisella, PJ; Robert, PY | 1 |
| Bechrakis, NE; Philipp, W; Speicher, L; Steger, B | 1 |
| Capita, L; Chalita, MR; dos Santos-Neto, LL | 1 |
| Kang, Q; Li, L; Wang, S; Zheng, X | 1 |
| Chen, X; Chua, WH; Chuan, JC; Gong, L; Gu, Y; Ma, Z; Shao, Y; Sun, X; Tang, L; Tong, L; Wang, Q; Xu, X; Yao, K; Yuan, H | 1 |
| Fukui, M; Kamoi, M; Kawakita, T; Mukai, S; Ogawa, Y; Saijo-Ban, Y; Simmura, S; Tsubota, K; Yaguchi, S; Yamane, M | 1 |
| Augé, M; Blanch, El; Cardona, G; Quevedo, L; Serés, C | 1 |
| Dunn, SP; Kim, C; Sosne, G | 1 |
| Tan, CL; Tong, L; Zhao, Y | 1 |
| Guo, Q; Huang, H; Pi, Y; Zhang, H | 1 |
| Maeda, Y; Matsumiya, W; Nagai, T; Nakamura, M; Otsuka, K; Ueda, K | 1 |
| Abelson, MB; Angjeli, E; Lane, KJ; Ousler, GW; Rodriguez, JD; Smith, LM | 1 |
| Imamoglu, S; Sevim, MS; Tukenmez-Dikmen, N; Turan-Vural, E; Yildiz, EH | 1 |
| Billson, FA; Ooi, KG; Wakefield, D; Watson, SL | 1 |
| Geerling, G; Grigoleit, GU; Menrath, J; Meyer-ter-Vehn, T; Schargus, M | 1 |
| Chae, JB; Hyung, S; Kim, JH; Kim, KT; Kong, YT | 1 |
| Acir, NO; Cetinkaya, S; Cetinkaya, YF; Dadaci, Z; Mestan, E; Yener, HI | 1 |
| Begley, CG; Bradley, A; Braun, R; King-Smith, E; Port, N; Wu, Z | 1 |
| Acar, M; Ergin, C; Gönül, M; Gürdal, C; Kaya Akış, H | 1 |
| Graham, AD; Lin, MC; Yeh, TN | 1 |
| Kono, T; Ohashi, Y; Ohta, K; Shiraishi, A; Yamaguchi, M; Yoshioka, E | 1 |
| Connell, S; Cui, X; Hirayama, M; Kawakita, T; Liu, Y; Tsubota, K | 1 |
| Eom, Y; Keun Lee, H; Lee, JS; Myung Kim, H; Suk Song, J | 1 |
| Sabour, S | 1 |
| Chen, W; Li, J; Liu, H; Lu, H; She, Y; Simmons, PA; Vehige, JG; Xiao, B | 1 |
| Contreras-Ruiz, L; Krauss, AH; Masli, S; Mir, FA; Turpie, B | 1 |
| Alekseev, VN; Andryukhina, OM; Bezditko, PA; Brzheskiy, VV; Efimova, EL; Egorov, EA; Fedorkin, ON; Gusarevich, OG; Kamenskikh, TG; Karger, EM; Korol, AR; Lebedev, OI; Miljudin, ES; Mironov, AN; Muzhychuk, OP; Nasinnyk, IO; Ostapenko, V; Popeko, NA; Ryabtseva, AA; Savchenko, AY; Shaidurova, KN; Skulachev, MV; Skulachev, VP; Sumarokova, ES; Surov, AV; Vorontsova, TN; Vygodin, VA; Yani, EV | 1 |
| Chung, JK; Lee, SJ; Park, DH; Seo, DR | 1 |
| Ousler, G; Perekhvatova, N; Petrov, A; Skulachev, M; Stein, L | 1 |
| Gupta, RC; Khan, P; Kushwaha, RN; Mohan, S; Ranjan, R | 1 |
| Arai, H; Fukagawa, K; Hata, S; Kawakita, T; Okano, T; Sakatani, K; Shimazaki, S; Tanaka, M; Toda, I; Tsubota, K; Uchino, M; Yoshino, K | 1 |
| Yao, Q; Zhang, J; Zhang, Y; Zhou, D; Zhou, J | 1 |
| Ohashi, Y; Shiraishi, A; Yamaguchi, M; Yoshioka, E | 1 |
| Cools, N; Cos, P; De Meester, I; Delputte, P; Joossen, C; Joossens, J; Koppen, C; Lambeir, AM; Lanckacker, E; Maes, L; Zakaria, N | 1 |
| Chen, J; Hu, L; Huang, J; Sun, X; Wang, Q; Xie, W; Zhang, D; Zhang, L | 1 |
| Al Anazi, FF; Chikh, M; Courrier, E; Fournier, C; Gain, P; He, Z; Hor, G; Lépine, T; Thuret, G; Urrea, C | 1 |
| Asbell, P; Barry, B; Fujitani, K; Gadaria, N; Lee, KI | 1 |
| Enríquez-de-Salamanca, A; García-Vázquez, C; Gutiérrez-Gutiérrez, S; López-Miguel, A | 1 |
| Dotrelova, D; Fales, I; Jiraskova, N; Jirsova, K; Mahelkova, G; Palos, M; Seidler Stangova, P; Vesela, V | 1 |
| Chen, Y; Gong, L; Hong, J; Le, Q; Xu, J | 1 |
| Isa, NA; Markoulli, M; Papas, EB | 1 |
| Hyon, JY; Jin, KW; Park, SG; Ro, JW; Shin, YJ; Wee, WR | 1 |
| Chung, SK; Chung, SY; Doh, SH; Hwang, HS; Kim, EC; Kim, MS; Shin, MC; Yoon, SY | 1 |
| Li, X; Liu, Z; Lv, H; Qiu, W; Wang, W; Xu, T; Zhang, M | 1 |
| Craig, JP; Lim, J; Mooi, JK; Müller, A; Wang, MTM | 1 |
| Craciun, C; Mera, M; Mogosan, C; Samoila, O; Stan, C; Visan, O | 1 |
| Begley, CG; Chen, M; Garcia, M; Harrison, WW; Liu, H; Smith, JA | 1 |
| Donnenfeld, ED; Greenman, HE; Perry, AR; Perry, HD; Savage, HE; Solomon, R; Wittpenn, JR | 1 |
| Dana, R; Ecoiffier, T; El Annan, J; Rashid, S; Schaumberg, D | 1 |
| Chuck, RS; Kohanim, S; Park, CY; Parker, JS; Shen, J; Yew, M; Zhang, C; Zhu, L | 1 |
| Chen, JJ; Pflugfelder, SC; Rao, K | 1 |
| García-Resúa, C; Giraldez, MJ; Lira, M; Santodomingo-Rubido, J; Vilar, EY | 1 |
| Xu, J; Zhou, X; Zhuang, H | 1 |
| Alvarez-Barrientos, A; Arriola-Villalobos, P; Benitez-Del-Castillo, JM; de la Heras, B; Diaz-Valle, D; Giron, N; Herrero Vanrell, R; Sanchez, MA; Torralbo-Jimenez, P | 1 |
| Jiang, C; Sun, X; Wang, X; Wang, Y; Xu, J; Zhuang, H | 1 |
| Blackie, CA; Exford, JM; Finnemore, VM; Greiner, JV; Herman, JP; Korb, DR; Scaffidi, RC | 1 |
| Glasgow, BJ; Hopp, LM; Sikh, PK; Thinda, S | 1 |
| Miyake, Y; Mizuno, Y; Yamada, M | 1 |
| Malta, JB; Mian, SI; Musch, DC; Rhoades, W; Shtein, RM; Soong, HK; Sugar, A | 1 |
| Alonso-Caneiro, D; Collins, MJ; Iskander, DR; Read, SA; Szczesna, DH | 1 |
| Dogru, M; Goto, E; Hosaka, E; Kawamorita, T; Nakayama, N; Ogasawara, Y; Shimizu, K; Tsubota, K; Uozato, H | 1 |
| Chen, Q; Chen, W; Cui, L; Lu, F; Ma, H; Zhang, X | 1 |
| Casey, R; Glasgow, BJ; Mokhtarzadeh, M | 1 |
| Bai, L; He, H; Lin, Z; Liu, X; Liu, Z; Wang, Y; Zhou, T | 1 |
| Almaraz, A; Calonge, M; Cordero, Y; Fuentes-Páez, G; González, MJ; Herreras, JM | 1 |
| Im, SK; Kim, HG; Yoon, KC; You, IC | 1 |
| Dogru, M; Goto, E; Hara, S; Ishida, R; Kaido, M; Kojima, T; Matsumoto, Y; Shimazaki, J; Tsubota, K | 1 |
| Dogru, M; Ishida, R; Kaido, M; Tsubota, K | 2 |
| Bıçakçıgil, M; Çiftçi, F; Utine, CA; Yavuz, S | 1 |
| Pult, H; Riede-Pult, BH | 1 |
| Bandamwar, KL; Garrett, Q; Papas, EB | 1 |
| Chauhan, SK; Dana, R; Lee, HS; Nallasamy, N; Okanobo, A | 1 |
| Chen, Q; Chen, W; Cui, L; Huang, Q; Lu, F; Ma, H; Zhang, X | 1 |
| Dogru, M; Tsubota, K; Uchino, M; Uchino, Y; Ward, S; Yokoi, N | 1 |
| Dogru, M; Ishida, R; Kaido, M; Matsumoto, Y; Shigeno, Y; Tsubota, K | 1 |
| Bickle, KM; Haque, RM; Nichols, JJ; Nichols, KK; Schiewe, MD; Zink, RC | 1 |
| Meadows, JF; Nichols, JJ; Nichols, KK; Ramamoorthy, P | 1 |
| Huang, D; Li, Y; Nguyen, P; Pappuru, RR; Ramos, S; Sadda, SR; Yiu, SC | 1 |
| Hida, RY; Kasahara, N; Neves Mendes, CR | 1 |
| Hirsh, AJ; Johnson, MR; Kublin, CL; Thelin, WR; Zoukhri, D | 1 |
| Cardona, G; Fornieles, A; Julio, G; Lluch, S; Merindano, D | 1 |
| Alfaro, J; Hernandez, H; Huidobro, A; Urzua, CA; Vasquez, DH | 1 |
| Han, SB; Hwang, JM; Hyon, JY; Yang, HK | 1 |
| Chuck, RS; Zhang, C; Zhu, L | 1 |
| Igarashi, A; Ishii, R; Kamiya, K; Kobashi, H; Nakanishi, M; Sato, N; Shimizu, K | 1 |
| Ohashi, Y; Takamura, E; Tsubota, K; Watanabe, H | 1 |
| Chim, K; Golebiowski, B; Jalbert, I; So, J | 1 |
| Berta, A; Fodor, E; Grupcheva, C; Higazy, M; Hlavackova, K; Kemer, OE; Komár, T; Kosina-Hagyó, K; Lang, Z; Németh, J; Petricek, I; Prost, M; Samaha, A; Schollmayer, P | 1 |
| Mahawong, W; Prabhasawat, P; Tesavibul, N | 1 |
| Bianchi, PE; Pasinetti, GM; Rossi, GC; Scudeller, L | 1 |
| Chen, Y; Evans, C; Floyd, AM; Rompala, OJ; Wang, M; Zhou, X; Zhu, L | 1 |
| Casey, R; Glasgow, BJ; Yeh, PT | 1 |
| Amos, N; Ansari, EA; Camilleri, JP; Kallarackal, GU; Lane, C; Martin, JC | 1 |
| Exford, JM; Finnemore, VM; Glonek, T; Greiner, JV; Hebert, E; Herman, JP; Korb, DR; Olson, MC | 1 |
| Matsuo, T; Morimoto, N; Tsuchida, Y | 1 |
| García Lozano, I; López García, JS; Martínez Garchitorena, J | 2 |
| Finnemore, VM; Glonek, T; Greiner, JV; Isreb, MA; Korb, DR; Mody, SS; Reddy, CV | 1 |
| Beuerman, R; Hamano, T; Nakamura, M; Nakata, K; Nguyen, D; Toshida, H | 1 |
| Ishiguro, K; Shigemitsu, T; Shimizu, Y | 1 |
| Aranguez, C; Benitez-del-Castillo, JM; Garcia-Sanchez, J | 1 |
| Cooper, P; Girard-Claudon, K; Guillon, M; Maissa, C | 1 |
| Al-Oliky, S; Begley, CG; Renner, D; Simpson, T; Wilson, G | 1 |
| Carmolli, T; Hall, B; Higgins, D; Huebner, D; Shapleigh, S; Webb, K | 1 |
| Hata, H; Hori, S; Shinozaki, K; Takamura, E; Yukari, J | 1 |
| Hori, S; Shinozaki, K; Takamura, E; Yukari, J | 1 |
| Bron, AJ; Evans, VE; Smith, JA | 1 |
| Bergmanson, J; Jackson, J; Miller, WL; Narayanan, S | 1 |
| Avunduk, AM; Avunduk, MC; Kaufman, HE; Varnell, ED | 1 |
| Berghold, A; Bodner, E; Floegel, I; Haller-Schober, EM; Horwath-Winter, J; Schmut, O; Schwantzer, G; Solhdju, V | 1 |
| Amano, S; Miyata, K; Nishida, T; Sawa, M | 1 |
| Calis, KA; Goodman, LA; Grieshaber, SA; Nelson, LM; Reed, GF; Smith, JA; Vanderhoof, VH; Vitale, S | 1 |
| Mitchell, GL; Nichols, KK; Zadnik, K | 1 |
| Dogru, M; Goto, E; Kaido, M; Tsubota, K | 1 |
| Baykara, M; Dogru, M; Goto, E; Karakaya, H; Kojima, T; Koksal, N; Matsumoto, Y; Ozmen, A; Shimazaki, J; Tsubota, K | 1 |
| Aragona, P; Ferreri, F; Mobrici, M; Stilo, A | 1 |
| Benzie, IF; Cho, P; Choy, CK; Choy, EP; To, TS | 1 |
| Mitchell, GL; Nichols, JJ; Nichols, KK | 1 |
| Bokosky, JE; Davitt, WF; Kellerman, DJ; LaVange, LM; Mills-Wilson, MC; Nichols, KK; Schaberg, AE; Tauber, J; Yerxa, BR | 1 |
| Blackie, CA; Douglass, T; Exford, JM; Finnemore, VM; Greiner, JV; Herman, JP; Korb, DR; Scaffidi, RC | 1 |
| Dogru, M; Goto, E; Ishida, R; Kaido, M; Kojima, T; Matsumoto, Y; Tsubota, K | 1 |
| Yazici, B | 1 |
| Di Pascuale, MA; Gao, YY; Liu, DT; Sawai, J; Tseng, SC | 1 |
| Gabler, B; Herrmann, WA; Hufendiek, K; Lohmann, CP; Shah, CP; von Mohrenfels, CW | 1 |
| Baeyens, V; Baudouin, C; Brignole, F; Dupas, B; Pisella, PJ | 1 |
| Chang, YH; Li, WC; Lin, HJ | 1 |
| Barabino, S; Chen, L; Dana, MR; Rashid, S; Rolando, M; Shen, L | 1 |
| Bates, AK; Ewings, P; McDermott, B; Saleh, TA | 1 |
| Berghold, A; Fischl, M; Haller-Schober, EM; Horwath-Winter, J; Schwantzer, G; Theisl, A | 1 |
| Di Pascuale, MA; Liu, TS; Trattler, W; Tseng, SC | 1 |
| Chalmers, RL; Pence, N; Riley, C | 1 |
| Guillon, M; Maissa, C | 1 |
| Amano, S; Miyai, T; Miyata, K; Nejima, R; Otani, S | 1 |
| Begley, CG; Chalmers, R; Himebaugh, N; Liu, H; Renner, D; Simpson, T; Varikooty, J | 1 |
| Dogru, M; Goto, E; Ishida, R; Kojima, T; Matsumoto, Y; Tsubota, K | 1 |
| Kodama, T; Kutsuna, M; Ohashi, Y; Uno, T; Yamaguchi, M; Zheng, X | 1 |
| Hinkle, DM | 1 |
| Asbell, PA; Fahim, MM; Fan, VC; Haji, S; Koonapareddy, CV | 1 |
| Corrales, RM; De Paiva, CS; Li, DQ; Pflugfelder, SC; Stern, ME; Welch, J | 1 |
| Begley, CG; Chalmers, R; Liu, H; Srinivas, SP; Wilkinson, JA; Wilson, G | 1 |
| Farjo, QA; Gupta, A; Lelli, GJ; Mian, SI; Musch, DC; Nairus, TM | 1 |
| Erdogan-Poyraz, C; Irkec, M; Mocan, MC; Orhan, M | 1 |
| Akova, YA; Altinors, DD; Bozbeyoglu, S; Karabay, G | 1 |
| Goto, E; Inoue, M; Kawai, M; Kawashima, M; Mashima, Y; Tsubota, K; Yamada, M | 1 |
| Heo, H; Im, SK; Kim, YH; Park, YG; Yoon, KC; You, IC | 1 |
| Bouchard, CS; Galasso, JM; Russo, PA | 1 |
| Ardan, T; Brunová, B; Cejka, C; Cejková, J; Dotrelová, D; Filipec, M; Jechová, G; Jirsová, K; Malec, J; Simonová, Z | 1 |
| Chen, SX; Lee, GA | 2 |
| Cedrone, R; Evans, D; Helbert-Green, C; Shah, T; Zigler, L | 1 |
| Beuerman, RW; Murakami, A; Nguyen, DH; Toshida, H | 1 |
| Blackie, CA; Exford, JM; Finnemore, VM; Herman, JP; Korb, DR | 1 |
| Barabino, S; Dana, MR; Ecoiffier, T; Jin, Y; Rashid, S; Schaumberg, DA | 1 |
| Dean, SJ; Moore, JE; Moore, TC; Novitskaya, ES; Sharma, A | 1 |
| Burgess, PI; Clark, P; Koay, P | 1 |
| Toda, I; Tsubota, K | 1 |
| Kinoshita, S; Yokoi, N | 1 |
| Bruce, AS; Golding, TR; Mainstone, JC | 2 |
| Fujihara, T; Takeuchi, T; Tsubota, K | 1 |
| Härkönen, M; Honkanen, N; Konttinen, YT; Tervo, T; Virtanen, T | 1 |
| Danjo, Y | 1 |
| Hong, JW; Kim, HM | 1 |
| Lowther, GE; Slusser, TG | 1 |
| Goto, E; Ono, M; Tsubota, K; Yagi, Y; Yang, HY | 1 |
| Fujihara, T; Saito, K; Takeuchi, T; Tsubota, K | 1 |
| Hutnik, CM; Probst, LE | 1 |
| Afonso, AA; Feuer, WJ; Monroy, D; Pflugfelder, SC; Stern, ME; Tseng, SC | 1 |
| Fujihara, T; Kaido, M; Shimmura, S; Tsubota, K; Yagi, Y | 1 |
| Liu, Z; Pflugfelder, SC | 1 |
| Macri, A; Pflugfelder, S; Rolando, M | 1 |
| Nichols, JJ; Nichols, KK; Zadnik, K | 1 |
| Korb, DR | 1 |
| Kinoshita, S; Oguz, H; Yokoi, N | 1 |
| Albietz, JM | 1 |
| Fujihara, T; Fujita, H; Murakami, T; Nakamura, M; Nakata, K | 1 |
| Battat, L; Dursun, D; Macri, A; Pflugfelder, SC | 1 |
| Greiner, JV; Herman, J; Korb, DR | 1 |
| Jager, MJ; Keijser, S; van Best, JA; Van der Lelij, A | 1 |
| Huang, G; Wang, Z; Wu, J; Xu, Z; Yang, B | 1 |
| Albietz, JM; Earl, ML; Lenton, LM; McLennan, SG | 1 |
| Göbbels, M; Spitznas, M | 3 |
| Göbbels, M; Selbach, J; Spitznas, M | 1 |
| Lee, JH; Lim, KJ | 1 |
| Ahluwalia, BK; Chaudhary, R; Gupta, S; Khurana, AK | 1 |
9 review(s) available for fluorescein and Dry Eye
| Article | Year |
|---|---|
Effect of Intense Pulsed Light Therapy in Dry Eye Disease Caused by Meibomian Gland Dysfunction: A Systematic Review and Meta-Analysis.
Topics: Dry Eye Syndromes; Fluorescein; Humans; Intense Pulsed Light Therapy; Lipids; Lubricant Eye Drops; Meibomian Gland Dysfunction; Meibomian Glands; Tears | 2022 |
Intense pulsed light (IPL) therapy for meibomian gland dysfunction (MGD)-related dry eye disease (DED): a systematic review and meta-analysis.
Topics: Dry Eye Syndromes; Fluorescein; Humans; Intense Pulsed Light Therapy; Meibomian Gland Dysfunction; Meibomian Glands | 2022 |
Ocular surface staining: Current concepts and techniques.
Topics: Cornea; Dry Eye Syndromes; Fluorescein; Humans; Lissamine Green Dyes; Staining and Labeling; Tears | 2023 |
TFOS DEWS II Diagnostic Methodology report.
Topics: Dry Eye Syndromes; Fluorescein; Humans; Keratoconjunctivitis Sicca; Osmolar Concentration; Tears | 2017 |
Design, Synthesis, and Some Aspects of the Biological Activity of Mitochondria-Targeted Antioxidants.
Topics: Ammonium Compounds; Antioxidants; Benzoquinones; Drug Design; Dry Eye Syndromes; Fluorescein; Humans; Mitochondria; Oxidative Phosphorylation; Plastoquinone; Reactive Oxygen Species | 2017 |
Short Tear Film Breakup Time-Type Dry Eye.
Topics: Dry Eye Syndromes; Fluorescein; Fluorescent Dyes; Humans; Lacrimal Apparatus Diseases; Rose Bengal; Staining and Labeling; Tears; Vision Disorders | 2018 |
Efficacy of Omega-3 Fatty Acid Supplementation for Treatment of Dry Eye Disease: A Meta-Analysis of Randomized Clinical Trials.
Topics: Cornea; Dietary Supplements; Dry Eye Syndromes; Fatty Acids, Omega-3; Fluorescein; Humans; Randomized Controlled Trials as Topic; Tears | 2019 |
Fluorescein-tear breakup time as an assessment of efficacy of tear replacement therapy in dry eye patients: a systematic review and meta-analysis.
Topics: Dry Eye Syndromes; Fluorescein; Humans; Lubricant Eye Drops; Tears | 2014 |
Grading of corneal and conjunctival staining in the context of other dry eye tests.
Topics: Coloring Agents; Conjunctiva; Contrast Media; Cornea; Dry Eye Syndromes; Fluorescein; Fluorescent Dyes; Humans; Lissamine Green Dyes; Rose Bengal; Staining and Labeling | 2003 |
75 trial(s) available for fluorescein and Dry Eye
| Article | Year |
|---|---|
A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase 2B/3 ESSENCE Study.
Topics: Administration, Ophthalmic; Adolescent; Adult; Aged; Aged, 80 and over; Conjunctiva; Cornea; Cyclosporine; Double-Blind Method; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Immunosuppressive Agents; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Staining and Labeling; Treatment Outcome; Water | 2021 |
Comparison of the influence of light between circularly polarized and linearly polarized smartphones on dry eye symptoms and asthenopia.
Topics: Asthenopia; Dry Eye Syndromes; Fluorescein; Humans; Smartphone; Tears | 2022 |
TNF-α inhibitor tanfanercept (HBM9036) improves signs and symptoms of dry eye in a phase 2 trial in the controlled adverse environment in China.
Topics: Double-Blind Method; Dry Eye Syndromes; Fluorescein; Humans; Immunosuppressive Agents; Ophthalmic Solutions; Tears; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha | 2022 |
Sodium hyaluronate 0.30% ocular gel versus sodium hyaluronate 0.18% eye drop in the treatment of moderate to severe dry eye disease.
Topics: Conjunctiva; Dry Eye Syndromes; Fluorescein; Humans; Hyaluronic Acid; Ophthalmic Solutions; Tears | 2023 |
Efficacy and Safety of the Long-Acting Diquafosol Ophthalmic Solution DE-089C in Patients with Dry Eye: A Randomized, Double-Masked, Placebo-Controlled Phase 3 Study.
Topics: Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Dry Eye Syndromes; Fluorescein; Humans; Ophthalmic Solutions; Polyphosphates; Tears; Treatment Outcome; Uracil Nucleotides | 2022 |
Efficacy and Safety of Single-dose OC-02 (Simpinicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The PEARL Phase II Randomized Trial.
Topics: Adult; Double-Blind Method; Dry Eye Syndromes; Fluorescein; Humans; Nasal Sprays; Ophthalmic Solutions; Receptors, Nicotinic; Varenicline | 2022 |
Cyclosporine A (0.05%) Ophthalmic Gel in the Treatment of Dry Eye Disease: A Multicenter, Randomized, Double-Masked, Phase III, COSMO Trial.
Topics: Cyclosporine; Double-Blind Method; Dry Eye Syndromes; Fluorescein; Gels; Humans; Immunosuppressive Agents; Ophthalmic Solutions; Tears; Treatment Outcome | 2022 |
The effect of eye care protocol on the prevention of ocular surface disorders in patients admitted to intensive care unit.
Topics: Conjunctivitis; Dry Eye Syndromes; Fluorescein; Humans; Intensive Care Units; Keratitis; Ulcer | 2022 |
NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction: Results of the Randomized Phase 3 GOBI Study.
Topics: Adult; Double-Blind Method; Dry Eye Syndromes; Fluorescein; Humans; Meibomian Gland Dysfunction; Meibomian Glands; Ophthalmic Solutions; Tears | 2023 |
A phase 2a, double-masked, randomized, vehicle-controlled trial of VVN001 in subjects with dry eye disease.
Topics: Double-Blind Method; Dry Eye Syndromes; Fluorescein; Humans; Ophthalmic Solutions; Treatment Outcome | 2023 |
NOV03 for Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction: The Randomized Phase 3 MOJAVE Study.
Topics: Administration, Ophthalmic; Dry Eye Syndromes; Fluorescein; Humans; Infant, Newborn; Meibomian Gland Dysfunction; Meibomian Glands; Ophthalmic Solutions; Tears | 2023 |
Efficacy and safety of topical 2% rebamipide ophthalmic suspension in dry eye disease at tertiary care centre.
Topics: Case-Control Studies; Dry Eye Syndromes; Fluorescein; Humans; Ophthalmic Solutions; Prospective Studies; Rose Bengal; Suspensions; Tears; Tertiary Care Centers | 2023 |
Safety and efficacy of cyclosporine (0.05% versus 0.09%) in dry eye disease. Is it the strength of cyclosporin that really matters?
Topics: Conjunctiva; Cyclosporine; Dry Eye Syndromes; Fluorescein; Humans | 2022 |
Acupuncture for aqueous deficiency dry eye: a randomized controlled trial.
Topics: Acupuncture Therapy; Dry Eye Syndromes; Eye; Fluorescein; Humans; Hyaluronic Acid; Ophthalmic Solutions; Tears | 2023 |
Efficacy of the Fluorescein Tear Breakup Time Test in Dry Eye.
Topics: Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Middle Aged; ROC Curve; Tears; Video Recording | 2020 |
The Effect of Long-Term Use of an Eyewash Solution on the Ocular Surface Mucin Layer.
Topics: Adult; CA-125 Antigen; Conjunctiva; Cornea; Dry Eye Syndromes; Female; Fluorescein; Glycyrrhizic Acid; Goblet Cells; Humans; Japan; Male; Membrane Proteins; Mucin 5AC; Ophthalmic Solutions; Prospective Studies; Tears | 2019 |
Effect of a formulated eye drop with
Topics: Adolescent; Adult; Apitherapy; Double-Blind Method; Drug Compounding; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Honey; Humans; Leptospermum; Lubricant Eye Drops; Male; Pharmaceutical Preparations; Prospective Studies; Staining and Labeling; Surveys and Questionnaires; Tears; Visual Acuity; Young Adult | 2020 |
Effect of warming eyelids on tear film stability and quality of life in visual display terminal users: a randomized controlled trial.
Topics: Adult; Dry Eye Syndromes; Eyelids; Female; Fluorescein; Humans; Male; Meibomian Glands; Prospective Studies; Quality of Life; Tears; Vision, Ocular | 2020 |
A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye Disease.
Topics: Administration, Ophthalmic; Adult; Aged; Aged, 80 and over; Double-Blind Method; Dry Eye Syndromes; Female; Fluorescein; Fluorocarbons; Fluorophotometry; Humans; Male; Meibomian Gland Dysfunction; Middle Aged; Ophthalmic Solutions; Prospective Studies; Staining and Labeling; Surveys and Questionnaires; Tears; Treatment Outcome; Visual Analog Scale; Young Adult | 2021 |
Early Onset and Broad Activity of Reproxalap in a Randomized, Double-Masked, Vehicle-Controlled Phase 2b Trial in Dry Eye Disease.
Topics: Administration, Ophthalmic; Aged; Aldehyde Dehydrogenase; Aminoquinolines; Cornea; Dose-Response Relationship, Drug; Double-Blind Method; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Middle Aged; Ophthalmic Solutions; Staining and Labeling; Tears; Treatment Outcome | 2021 |
Reliability and efficacy of maximum fluorescein tear break-up time in diagnosing dry eye disease.
Topics: Adult; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Prospective Studies; Tears | 2021 |
An investigation into the effects of ocular nebulization combined with meibomian gland massage on ocular surface status and corneal higher-order aberrations for the treatment of meibomian gland dysfunction.
Topics: Azithromycin; Digitalis Glycosides; Dry Eye Syndromes; Esculin; Eyelid Diseases; Fluorescein; Humans; Massage; Meibomian Gland Dysfunction; Meibomian Glands; Ophthalmic Solutions; Prospective Studies; Tears | 2022 |
Tear film interferometry assessment after intense pulsed light in dry eye disease: A randomized, single masked, sham-controlled study.
Topics: Dry Eye Syndromes; Fluorescein; Humans; Interferometry; Lubricant Eye Drops; Meibomian Glands; Prospective Studies; Tears | 2022 |
One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease.
Topics: Adult; Aged; Cyclosporine; Double-Blind Method; Dry Eye Syndromes; Emulsions; Female; Fluorescein; Humans; Immunosuppressive Agents; Keratitis; Male; Middle Aged; Ophthalmic Solutions; Tears | 2017 |
Comparative Evaluation of Clinical Methods of Tear Film Stability Assessment: A Randomized Crossover Trial.
Topics: Adult; Corneal Topography; Cross-Over Studies; Double-Blind Method; Dry Eye Syndromes; False Positive Reactions; Female; Fluorescein; Fluorescent Dyes; Humans; Likelihood Functions; Male; Predictive Value of Tests; Prospective Studies; ROC Curve; Sensitivity and Specificity; Tears; Young Adult | 2018 |
Reduced Efficacy of Low-dose Topical Steroids in Dry Eye Disease Associated With Graft-versus-Host Disease.
Topics: Administration, Ophthalmic; Anti-Allergic Agents; Chronic Disease; Conjunctiva; Double-Blind Method; Dry Eye Syndromes; Female; Fluorescein; Fluorophotometry; Glucocorticoids; Graft vs Host Disease; Humans; Loteprednol Etabonate; Lubricant Eye Drops; Male; Middle Aged; Prospective Studies; Staining and Labeling; Surveys and Questionnaires; Tears; Treatment Outcome | 2018 |
A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease.
Topics: Administration, Ophthalmic; Aged; Cornea; Cyclosporine; Double-Blind Method; Drug Compounding; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Immunosuppressive Agents; Male; Middle Aged; Ophthalmic Solutions; Quality of Life; Sickness Impact Profile; Tears; Treatment Outcome; Visual Analog Scale | 2019 |
Randomised trial of the clinical utility of an eyelid massage device for the management of meibomian gland dysfunction.
Topics: Adult; Coloring Agents; Double-Blind Method; Dry Eye Syndromes; Eyelids; Female; Fluorescein; Fluorescent Dyes; Humans; Lissamine Green Dyes; Male; Massage; Meibomian Gland Dysfunction; Prospective Studies; Surveys and Questionnaires; Tears; Young Adult | 2019 |
Collared silicone punctal plugs compared to intracanalicular plugs for the treatment of dry eye.
Topics: Dry Eye Syndromes; Fluorescein; Fluorescent Dyes; Follow-Up Studies; Humans; Lacrimal Apparatus; Meibomian Glands; Ophthalmic Solutions; Prospective Studies; Prosthesis Design; Prosthesis Implantation; Rose Bengal; Silicones; Single-Blind Method; Surgical Instruments | 2013 |
Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial.
Topics: Administration, Ophthalmic; Adult; Aged; Boston; Chi-Square Distribution; Diagnostic Techniques, Ophthalmological; Double-Blind Method; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Immunologic Factors; Interleukin 1 Receptor Antagonist Protein; Male; Meibomian Glands; Middle Aged; Ophthalmic Solutions; Predictive Value of Tests; Prospective Studies; Time Factors; Treatment Outcome | 2013 |
Evaluation of a thermosensitive atelocollagen punctal plug treatment for dry eye disease.
Topics: Collagen; Dry Eye Syndromes; Eyelids; Female; Fluorescein; Fluorescent Dyes; Hot Temperature; Humans; Lacrimal Apparatus; Male; Middle Aged; Prospective Studies; Prostheses and Implants; Prosthesis Implantation; Tears; Treatment Outcome | 2014 |
Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Conjunctiva; Cornea; Double-Blind Method; Dry Eye Syndromes; Female; Fluorescein; Fluorometry; Humans; Lissamine Green Dyes; Lymphocyte Function-Associated Antigen-1; Male; Middle Aged; Ophthalmic Solutions; Phenylalanine; Prospective Studies; Staining and Labeling; Sulfones; Treatment Outcome; Young Adult | 2014 |
The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study.
Topics: Administration, Topical; Cornea; Cross-Over Studies; Double-Blind Method; Dry Eye Syndromes; Female; Fluorescein; Fluorophotometry; Humans; Male; Middle Aged; Ophthalmic Solutions; Preservatives, Pharmaceutical; Prospective Studies; Serum; Tears; Treatment Outcome | 2014 |
Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
Topics: Aged; Drug Combinations; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Fluorophotometry; Humans; Hyaluronic Acid; Male; Middle Aged; Ophthalmic Solutions; Polyphosphates; Preservatives, Pharmaceutical; Purinergic P2Y Receptor Agonists; Rose Bengal; Tears; Uracil Nucleotides; Viscosupplements | 2014 |
Ocular tolerability and efficacy of a cationic emulsion in patients with mild to moderate dry eye disease - a randomised comparative study.
Topics: Administration, Ophthalmic; Aged; Drug Combinations; Dry Eye Syndromes; Emulsions; Female; Fluorescein; Humans; Lissamine Green Dyes; Male; Middle Aged; Ophthalmic Solutions; Polyvinyl Alcohol; Povidone; Severity of Illness Index; Tears; Treatment Outcome | 2014 |
In vivo confocal microscopic characterisation of the cornea in chronic graft-versus-host disease related severe dry eye disease.
Topics: Adult; Aged; Cell Count; Chronic Disease; Conjunctiva; Cornea; Corneal Keratocytes; Corneal Stroma; Cranial Nerve Diseases; Dendritic Cells; Dry Eye Syndromes; Endothelium, Corneal; Epithelium, Corneal; Extracellular Matrix; Female; Fluorescein; Graft vs Host Disease; Humans; Lissamine Green Dyes; Male; Microscopy, Confocal; Middle Aged; Ophthalmic Nerve; Prospective Studies; Stem Cell Transplantation; Tears; Transplantation, Homologous; Young Adult | 2015 |
Prospective evaluation of hypromellose 2% for punctal occlusion in patients with dry eye.
Topics: Dry Eye Syndromes; Eyelids; Female; Fluorescein; Fluorescent Dyes; Humans; Hypromellose Derivatives; Lacrimal Apparatus; Male; Ophthalmic Solutions; Prospective Studies; Rose Bengal; Single-Blind Method; Staining and Labeling; Tears | 2015 |
A randomised, parallel-group comparison study of diquafosol ophthalmic solution in patients with dry eye in China and Singapore.
Topics: Aged; Asian People; China; Dry Eye Syndromes; Fluorescein; Fluorescent Dyes; Humans; Hyaluronic Acid; Middle Aged; Ophthalmic Solutions; Polyphosphates; Purinergic P2Y Receptor Agonists; Rose Bengal; Singapore; Staining and Labeling; Tears; Treatment Outcome; Uracil Nucleotides; Viscosupplements | 2015 |
Tear break-up time for tear film evaluation: Are moistening solutions interchangeable?
Topics: Adult; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Guideline Adherence; Health Care Surveys; Humans; Male; Ophthalmic Solutions; Ophthalmology; Practice Guidelines as Topic; Tears; Young Adult | 2015 |
Thymosin β4 significantly improves signs and symptoms of severe dry eye in a phase 2 randomized trial.
Topics: Adult; Aged; Cornea; Double-Blind Method; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Fluorophotometry; Follow-Up Studies; Graft vs Host Disease; Humans; Male; Microfilament Proteins; Middle Aged; Ophthalmic Solutions; Surveys and Questionnaires; Tears; Thymosin | 2015 |
Intra-observer and inter-observer repeatability of ocular surface interferometer in measuring lipid layer thickness.
Topics: Adult; Cornea; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Interferometry; Lipids; Male; Meibomian Glands; Observer Variation; Prospective Studies; Reproducibility of Results; Surveys and Questionnaires; Tears; Young Adult | 2015 |
Reliability of a new modified tear breakup time method: dry tear breakup time.
Topics: Adult; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Prospective Studies; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Tears; Time Factors; Young Adult | 2015 |
Results of a Multicenter, Randomized, Double-Masked, Placebo-Controlled Clinical Study of the Efficacy and Safety of Visomitin Eye Drops in Patients with Dry Eye Syndrome.
Topics: Adult; Benzalkonium Compounds; Cornea; Double-Blind Method; Drug Combinations; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Methylcellulose; Middle Aged; Ophthalmic Solutions; Plastoquinone; Tears; Treatment Outcome; Visual Acuity | 2015 |
Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial.
Topics: Administration, Topical; Aged; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Hyaluronic Acid; Lens Implantation, Intraocular; Lissamine Green Dyes; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Polyphosphates; Prospective Studies; Purinergic P2Y Receptor Agonists; Staining and Labeling; Surveys and Questionnaires; Tears; Uracil Nucleotides; Viscosupplements; Visual Acuity | 2016 |
SkQ1 Ophthalmic Solution for Dry Eye Treatment: Results of a Phase 2 Safety and Efficacy Clinical Study in the Environment and During Challenge in the Controlled Adverse Environment Model.
Topics: Adolescent; Adult; Cornea; Dose-Response Relationship, Drug; Double-Blind Method; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Ophthalmic Solutions; Plastoquinone; Treatment Outcome; Young Adult | 2016 |
Randomized, Multicenter, Double-Blind Study of the Safety and Efficacy of 1%D-3-Hydroxybutyrate eye drops for Dry Eye Disease.
Topics: 3-Hydroxybutyric Acid; Adult; Aged; Animals; Conjunctiva; Cornea; Double-Blind Method; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Middle Aged; Ophthalmic Solutions; Patient Safety; Prospective Studies; Rats; Rose Bengal; Staining and Labeling; Tears | 2016 |
Temporal Characteristics of Sodium Fluorescein in the Tear Meniscus.
Topics: Adult; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Ophthalmic Solutions; Osmolar Concentration; Tears; Young Adult | 2017 |
Minimising instilled volume reduces the impact of fluorescein on clinical measurements of tear film stability.
Topics: Adolescent; Adult; Cross-Over Studies; Dose-Response Relationship, Drug; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Instillation, Drug; Male; Ophthalmic Solutions; Prospective Studies; Tears; Young Adult | 2017 |
Comparative analysis of carmellose 0.5% versus hyaluronate 0.15% in dry eye: a flow cytometric study.
Topics: Adult; Aged; Biomarkers; Carboxymethylcellulose Sodium; CD11b Antigen; CD3 Complex; Cornea; Double-Blind Method; Dry Eye Syndromes; Female; Flow Cytometry; Fluorescein; HLA-DR Antigens; Humans; Hyaluronic Acid; Middle Aged; Ophthalmic Solutions; Prognosis; Staining and Labeling; Tears | 2010 |
Mechanisms of superficial micropunctate corneal staining with sodium fluorescein: the contribution of pooling.
Topics: Adult; Animals; Contact Lens Solutions; Contact Lenses, Hydrophilic; Cornea; Dry Eye Syndromes; Fluorescein; Fluorescent Dyes; Follow-Up Studies; Humans; Rabbits; Single-Blind Method; Staining and Labeling; Young Adult | 2012 |
Safety and efficacy of topical azithromycin ophthalmic solution 1.0% in the treatment of contact lens-related dry eye.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Contact Lenses; Cornea; Dry Eye Syndromes; Female; Fluorescein; Humans; Imidazoles; Male; Middle Aged; Ophthalmic Solutions; Pilot Projects; Tears; Visual Acuity; Young Adult | 2012 |
Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome.
Topics: Conjunctiva; Cornea; Cross-Over Studies; Double-Blind Method; Dry Eye Syndromes; Female; Fluorescein; Fluorophotometry; Humans; Male; Middle Aged; Ophthalmic Solutions; Serum; Treatment Outcome | 2012 |
Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Hyaluronic Acid; Male; Middle Aged; Ophthalmic Solutions; Polyphosphates; Prospective Studies; Purinergic P2Y Receptor Agonists; Rose Bengal; Tears; Uracil Nucleotides; Viscosupplements | 2012 |
A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients.
Topics: Cornea; Double-Blind Method; Dry Eye Syndromes; Fluorescein; Fluorescent Dyes; Humans; Hyaluronic Acid; Ophthalmic Solutions; Polyphosphates; Rose Bengal; Treatment Outcome; Uracil Nucleotides; Viscosupplements | 2012 |
Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Antioxidants; Coloring Agents; Dose-Response Relationship, Drug; Double-Blind Method; Dry Eye Syndromes; Enzyme Inhibitors; Female; Fluorescein; Fluorophotometry; Humans; Lissamine Green Dyes; Male; Middle Aged; Ophthalmic Solutions; Quinolones; Treatment Outcome; Young Adult | 2012 |
A randomized double-masked study of 0.05% cyclosporine ophthalmic emulsion in the treatment of meibomian gland dysfunction.
Topics: Administration, Topical; Cyclosporine; Double-Blind Method; Dry Eye Syndromes; Emulsions; Eyelid Diseases; Female; Fluorescein; Humans; Immunosuppressive Agents; Male; Meibomian Glands; Middle Aged; Ophthalmic Solutions; Prospective Studies; Rose Bengal; Staining and Labeling; Tears; Treatment Outcome | 2012 |
A comparative study to assess the clinical use of Fluorescein Meniscus Time (FMT) with Tear Break up Time (TBUT) and Schirmer's tests (ST) in the diagnosis of dry eyes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Reproducibility of Results; Surface Properties; Tears | 2002 |
Trehalose eye drops in the treatment of dry eye syndrome.
Topics: Adult; Aged; Double-Blind Method; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Ophthalmic Solutions; Rose Bengal; Safety; Treatment Outcome; Trehalose | 2002 |
Mucin ophthalmic solution treatment of dry eye.
Topics: Adult; Aged; Contrast Media; Dry Eye Syndromes; Epithelium, Corneal; Fluorescein; Humans; Middle Aged; Mucins; Ophthalmic Solutions; Reference Values | 2002 |
Corneal epithelial permeability and dry eye treatment.
Topics: Adult; Benzalkonium Compounds; Contrast Media; Dose-Response Relationship, Drug; Drug Combinations; Dry Eye Syndromes; Epithelium, Corneal; Female; Fluorescein; Humans; Hyaluronic Acid; Male; Middle Aged; Ophthalmic Solutions; Permeability; Polyvinyl Alcohol; Preservatives, Pharmaceutical; Sjogren's Syndrome | 2002 |
The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study.
Topics: Administration, Topical; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Conjunctiva; Dry Eye Syndromes; Female; Fluorescein; Fluorometholone; Flurbiprofen; Glucocorticoids; Goblet Cells; HLA-DR Antigens; Humans; Male; Middle Aged; Ophthalmic Solutions; Periodic Acid-Schiff Reaction; Prospective Studies; Rose Bengal; Single-Blind Method; Treatment Outcome | 2003 |
Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjögren's syndrome patients.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cornea; Diclofenac; Dry Eye Syndromes; Epithelium, Corneal; Eye Diseases; Female; Fluorescein; Humans; Indomethacin; Male; Middle Aged; Ophthalmic Solutions; Sensation; Single-Blind Method; Sjogren's Syndrome; Statistics, Nonparametric; Treatment Outcome | 2005 |
Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye.
Topics: Administration, Topical; Conjunctiva; Contrast Media; Cornea; Double-Blind Method; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Ophthalmic Solutions; Polyphosphates; Purinergic P2 Receptor Agonists; Safety; Staining and Labeling; Tears; Treatment Outcome; Uracil Nucleotides | 2004 |
The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study.
Topics: Aged; Blood Proteins; Case-Control Studies; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Rose Bengal; Serum; Tears | 2005 |
Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis.
Topics: Aged; Carboxymethylcellulose Sodium; Conjunctiva; Cornea; Corneal Topography; Dose-Response Relationship, Drug; Dry Eye Syndromes; Female; Flow Cytometry; Fluorescein; Fluorescent Dyes; Follow-Up Studies; Humans; Hyaluronic Acid; Keratitis; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Severity of Illness Index; Single-Blind Method; Treatment Outcome; Viscosupplements | 2005 |
Clinical evaluation of the traditional chinese prescription Chi-Ju-Di-Huang-Wan for dry eye.
Topics: Adult; Aged; Diagnostic Techniques, Ophthalmological; Drugs, Chinese Herbal; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Ophthalmic Solutions; Phytotherapy; Plants, Medicinal; Surveys and Questionnaires; Treatment Outcome | 2005 |
Phenol red thread test vs Schirmer's test: a comparative study.
Topics: Adult; Aged; Aged, 80 and over; Dry Eye Syndromes; Female; Fluorescein; Humans; Indicators and Reagents; Male; Middle Aged; Phenolsulfonphthalein; Reagent Strips; Sensitivity and Specificity; Surveys and Questionnaires; Tears | 2006 |
The impact of lens choice in the relief of contact lens related symptoms and ocular surface findings.
Topics: Adult; Contact Lenses; Contact Lenses, Hydrophilic; Contrast Media; Cornea; Cross-Over Studies; Dry Eye Syndromes; Eye; Female; Fluorescein; Humans; Lissamine Green Dyes; Male; Middle Aged; Staining and Labeling; Tears; Time Factors | 2005 |
Clinical evaluation of silicone hydrogel lens wear with a new multipurpose disinfection care product.
Topics: Adolescent; Adult; Aged; Child; Contact Lens Solutions; Contact Lenses, Extended-Wear; Cornea; Double-Blind Method; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Male; Middle Aged; Ophthalmic Solutions; Preservatives, Pharmaceutical; Silicones; Staining and Labeling | 2007 |
SmartPlug versus silicone punctal plug therapy for dry eye: a prospective randomized trial.
Topics: Acrylic Resins; Adult; Aged; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Intraoperative Complications; Lacrimal Apparatus; Male; Middle Aged; Ophthalmic Solutions; Postoperative Complications; Prospective Studies; Prostheses and Implants; Rose Bengal; Silicone Elastomers; Tears; Treatment Outcome | 2008 |
Effects of lacrimal drainage occlusion with nondissolvable intracanalicular plugs on hydrogel contact lens wear.
Topics: Adult; Aged; Contact Lenses, Hydrophilic; Cornea; Double-Blind Method; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Fluorophotometry; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Lacrimal Apparatus; Lacrimal Duct Obstruction; Male; Middle Aged; Ophthalmic Solutions; Polyethylene Glycols; Prospective Studies; Rose Bengal; Silicone Elastomers; Tears | 1998 |
Argon laser punctal therapy versus thermal cautery for the treatment of aqueous deficiency dry eye syndrome.
Topics: Adult; Aged; Aqueous Humor; Contrast Media; Dry Eye Syndromes; Electrocoagulation; Female; Fluorescein; Hospitals, University; Humans; Lacrimal Apparatus; Laser Coagulation; Male; Middle Aged; Prospective Studies; Safety; Tears; Treatment Outcome | 1998 |
Comparison of fluorescein break-up time measurement reproducibility using standard fluorescein strips versus the Dry Eye Test (DET) method.
Topics: Adult; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Fluorescein; Humans; Middle Aged; Prospective Studies; Reagent Strips; Reproducibility of Results; Tears | 2001 |
[The early changes of tear film after laser in situ keratomileusis].
Topics: Adolescent; Adult; Cornea; Dry Eye Syndromes; Female; Fluorescein; Humans; Keratomileusis, Laser In Situ; Lacrimal Apparatus; Male; Myopia; Postoperative Complications; Rose Bengal; Tears | 2002 |
Effects of artificial tears on corneal epithelial permeability in dry eyes.
Topics: Cornea; Dry Eye Syndromes; Epithelium; Fluorescein; Fluoresceins; Fluorophotometry; Humans; Middle Aged; Ophthalmic Solutions; Permeability; Povidone-Iodine; Random Allocation | 1991 |
277 other study(ies) available for fluorescein and Dry Eye
| Article | Year |
|---|---|
Dry eye, its clinical subtypes and associated factors in healthy pregnancy: A cross-sectional study.
Topics: Adolescent; Adult; Blinking; Cross-Sectional Studies; Dry Eye Syndromes; Female; Fluorescein; Humans; Logistic Models; Multivariate Analysis; Pregnancy; Young Adult | 2021 |
Optogenetic Inhibition of Nav1.8 Expressing Corneal Afferents Reduces Persistent Dry Eye Pain.
Topics: Analgesia; Animals; Coatomer Protein; Cornea; Disease Models, Animal; Dry Eye Syndromes; Eye Pain; Female; Fluorescein; Fluorescent Dyes; Lacrimal Apparatus; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; NAV1.8 Voltage-Gated Sodium Channel; Neurons, Afferent; Ophthalmic Nerve; Optogenetics | 2021 |
Improving ocular surface comfort in contact lens wearers.
Topics: Contact Lenses, Hydrophilic; Dry Eye Syndromes; Fluorescein; Humans; Lubricant Eye Drops; Prospective Studies; Tears; Trehalose | 2022 |
MicroRNA Therapy for Dry Eye Disease.
Topics: Animals; Antagomirs; Benzalkonium Compounds; Cornea; Dry Eye Syndromes; Fluorescein; Meibomian Glands; Mice; MicroRNAs; Rabbits | 2022 |
Analysis of the first tear film break-up point in Sjögren's syndrome and non-Sjögren's syndrome dry eye patients.
Topics: Dry Eye Syndromes; Fluorescein; Humans; Meibomian Glands; Sjogren's Syndrome; Tears | 2022 |
A study of the association between Vitamin D deficiency and Dry Eye Syndrome (DES) in the Indian population.
Topics: Cross-Sectional Studies; Dry Eye Syndromes; Fluorescein; Humans; Tears; Vitamin D Deficiency | 2022 |
Transmembrane Mucin 1 Blocks Fluorescein Ingress to Corneal Epithelium.
Topics: Animals; Biological Transport; Blotting, Western; Cells, Cultured; Disease Models, Animal; Dry Eye Syndromes; Epithelium, Corneal; Flow Cytometry; Fluorescein; Fluorescent Dyes; Gene Expression; Gene Knockdown Techniques; Humans; Immunohistochemistry; Mucin-1; Rabbits; Real-Time Polymerase Chain Reaction; RNA, Small Interfering | 2022 |
Investigation of the relationship between ocular sarcoidosis and dry eye.
Topics: Aged; Aged, 80 and over; Dry Eye Syndromes; Endophthalmitis; Female; Fluorescein; Humans; Lacrimal Apparatus; Middle Aged; Sarcoidosis; Tears | 2022 |
Validation of a preclinical dry eye model in New Zealand white rabbits during and following topical instillation of 1% ophthalmic atropine sulfate.
Topics: Animals; Atropine; Dry Eye Syndromes; Fluorescein; Inflammation; Lacrimal Apparatus; Rabbits | 2022 |
The Role of Different Tear Volume Detection Methods in the Evaluation and Diagnosis of Mild Dry Eye Disease.
Topics: Cartilage Diseases; Dry Eye Syndromes; Fluorescein; Humans; Hyperplasia; Lacerations; Prospective Studies; Tears; Tomography, Optical Coherence | 2022 |
Tear meniscus, corneal topographic and aberrometric changes after botulinum toxin-a injection in patients with blepharospasm and hemifacial spasm.
Topics: Astigmatism; Blepharospasm; Botulinum Toxins, Type A; Coma; Corneal Topography; Dry Eye Syndromes; Fluorescein; Hemifacial Spasm; Humans; Neuromuscular Agents; Prospective Studies; Tears | 2022 |
Automated vs. human evaluation of corneal staining.
Topics: Cornea; Dry Eye Syndromes; Fluorescein; Humans; Software; Staining and Labeling | 2022 |
Transient effects of smoking on the eye.
Topics: Adolescent; Adult; Dry Eye Syndromes; Fluorescein; Humans; Lipids; Smoking; Tears; Young Adult | 2022 |
Rear 4-min Schirmer test, a modified indicator of Schirmer test in diagnosing dry eye.
Topics: Dry Eye Syndromes; Fluorescein; Humans; Meibomian Glands; Reproducibility of Results; Tears | 2022 |
Comparison of treatment effects between 4.9% N-acetyl-aspartyl glutamic acid and 0.05% cyclosporine A eye drops in dry eye patients.
Topics: Cyclosporine; Dry Eye Syndromes; Fluorescein; Glutamic Acid; Humans; Meibomian Gland Dysfunction; Meibomian Glands; Ophthalmic Solutions; Retrospective Studies; Tears | 2022 |
Tear Strip Meniscometry and Its Clinical Application: Analysis of More Than 2000 Cases.
Topics: Adult; Aged; Case-Control Studies; Cross-Sectional Studies; Dry Eye Syndromes; Fluorescein; Humans; Lacerations; Middle Aged; Pain | 2022 |
A new non-human primate model of desiccating stress-induced dry eye disease.
Topics: Animals; Dry Eye Syndromes; Fluorescein; Humans; Macaca mulatta; Rabbits; Tears | 2022 |
The effect of time on grading corneal fluorescein and conjunctival lissamine green staining.
Topics: Conjunctiva; Dry Eye Syndromes; Fluorescein; Humans; Lissamine Green Dyes; Staining and Labeling | 2022 |
The role of saffron in improvement of ocular surface disease in a mouse model of Lacrimal Gland Excision-induced dry eye disease.
Topics: Animals; Anti-Inflammatory Agents; Betamethasone; Crocus; Disease Models, Animal; Dry Eye Syndromes; Fluorescein; Lacrimal Apparatus; Mice; Tears | 2022 |
A Perspective on the Use of Fluorescent Imaging to Reveal Mechanisms of Breakup.
Topics: Coloring Agents; Dry Eye Syndromes; Fluorescein; Humans; Tears | 2022 |
Tear film instability is associated with weakened colocalization between occludin and MUC5AC in scopolamine-induced dry eye disease (DED) rats.
Topics: Animals; Dry Eye Syndromes; Fluorescein; Mucin 5AC; Occludin; Rats; Rats, Sprague-Dawley; Scopolamine; Tears | 2023 |
Ocular pain in ocular graft-versus-host disease patients with neurotrophic keratopathy.
Topics: Corneal Dystrophies, Hereditary; Dry Eye Syndromes; Eye Pain; Fluorescein; Graft vs Host Disease; Humans; Keratitis; Retrospective Studies; Tears; Trigeminal Nerve Diseases | 2022 |
Lacrimal gland injection of platelet rich plasma for treatment of severe dry eye: a comparative clinical study.
Topics: Adult; Dry Eye Syndromes; Fluorescein; Humans; Lacrimal Apparatus; Platelet-Rich Plasma; Tears | 2022 |
Tear matrix metalloproteinase-9 levels may help to follow a ocular surface injury in lagophthalmic eyes.
Topics: Adult; Dry Eye Syndromes; Eye Injuries; Eyelid Diseases; Fluorescein; Humans; Inflammation; Matrix Metalloproteinase 9; Osmolar Concentration; Tears | 2022 |
A plethora of ocular surface manifestations in a multidisciplinary ocular graft-versus-host disease unit.
Topics: Brazil; Dry Eye Syndromes; Expectorants; Fluorescein; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lubricants; Meibomian Gland Dysfunction; Ophthalmic Solutions; Retrospective Studies; Tetracyclines; Vision Disorders | 2022 |
Oil-free eye drops containing Cyclosporine A/cyclodextrin/PVA supramolecular complex as a treatment modality for dry eye disease.
Topics: Animals; Chickens; Cornea; Cyclodextrins; Cyclosporine; Dry Eye Syndromes; Female; Fluorescein; Humans; Mice; Ophthalmic Solutions; Scopolamine Derivatives | 2022 |
Differential response to topical lubrication in patient with dry eye disease, based on age.
Topics: Adult; Aged; Dry Eye Syndromes; Fluorescein; Humans; Lubrication; Middle Aged; Retrospective Studies; Tears | 2022 |
Ocular surface disorders affect quality of life in patients with autoimmune blistering skin diseases: a cross-sectional study.
Topics: Autoimmune Diseases; Blister; Corneal Opacity; Cross-Sectional Studies; Dry Eye Syndromes; Eyelid Diseases; Fluorescein; Humans; Meibomian Glands; Quality of Life; Skin Diseases; Surveys and Questionnaires; Tears | 2022 |
Transcorneal but not transpalpebral electrical stimulation disrupts mucin homeostasis of the ocular surface.
Topics: Animals; Conjunctiva; Dry Eye Syndromes; Electric Stimulation; Fluorescein; Goblet Cells; Homeostasis; Mice; Tears | 2022 |
Relationship between dry eye and expressions of CXCR3 and CCR5 after ocular acid burn.
Topics: Case-Control Studies; Dry Eye Syndromes; Fluorescein; Humans; Receptors, CCR5; Receptors, CXCR3; Reproducibility of Results; Tears | 2022 |
Evaluating the Differences Between Fluorescein Tear Break-up Time and Noninvasive Measurement Techniques.
Topics: Adult; Corneal Topography; Dry Eye Syndromes; Fluorescein; Humans; Interferometry; Middle Aged; Tears | 2023 |
Establishment of a Beagle Dog Model of Dry Eye Disease.
Topics: Animals; Dogs; Dry Eye Syndromes; Fluorescein; Interleukin-10; Interleukin-8; Tumor Necrosis Factor-alpha | 2023 |
Association between mask-associated dry eye (MADE) and corneal sensations.
Topics: Adult; Conjunctiva; Cornea; Dry Eye Syndromes; Fluorescein; Humans; Sensation; Tears; Young Adult | 2023 |
Classification of Tear Film Lipid Layer En Face Maps Obtained Using Optical Coherence Tomography and Their Correlation With Clinical Parameters.
Topics: Dry Eye Syndromes; Fluorescein; Humans; Lacerations; Lipids; Reproducibility of Results; Retrospective Studies; Tears; Tomography, Optical Coherence | 2023 |
Non-invasive and objective tear film breakup detection on interference color images using convolutional neural networks.
Topics: Dry Eye Syndromes; Fluorescein; Humans; Lacerations; Neural Networks, Computer; ROC Curve; Tears | 2023 |
Perfluorohexyloctane Eye Drops for Dry Eye Disease Associated With Meibomian Gland Dysfunction in Chinese Patients: A Randomized Clinical Trial.
Topics: Adult; Dry Eye Syndromes; East Asian People; Female; Fluorescein; Humans; Meibomian Gland Dysfunction; Meibomian Glands; Middle Aged; Ophthalmic Solutions; Sodium Chloride | 2023 |
Evaluation of Dry Eye With Videokeratographer Using a Newly Developed Indicator.
Topics: Cornea; Corneal Injuries; Cross-Sectional Studies; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Quality of Life; Tears | 2023 |
Efficacy and Safety of a Water-Free Topical Cyclosporine, 0.1%, Solution for the Treatment of Moderate to Severe Dry Eye Disease: The ESSENCE-2 Randomized Clinical Trial.
Topics: Cyclosporine; Double-Blind Method; Dry Eye Syndromes; Female; Fluorescein; Humans; Lubricant Eye Drops; Male; Middle Aged; Ophthalmic Solutions; Quality of Life; Tears; Treatment Outcome | 2023 |
Evaluation of dry eyes in children with vernal kerato-conjunctivitis using clinical tests and ocular surface analysis.
Topics: Child; Conjunctivitis, Allergic; Dry Eye Syndromes; Fluorescein; Humans; Keratoconus; Tears | 2023 |
Lid wiper epitheliopathy in symptomatic and asymptomatic dry eye subjects.
Topics: Adult; Coloring Agents; Cornea; Dry Eye Syndromes; Eyelids; Fluorescein; Humans; Young Adult | 2023 |
Study of tear function before and after laser-assisted
Topics: Cornea; Dry Eye Syndromes; Fluorescein; Humans; Keratomileusis, Laser In Situ; Lasers, Excimer; Myopia; Prospective Studies; Tears | 2023 |
Dry eye disease in head and neck cancer patients undergoing radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Dry Eye Syndromes; Female; Fluorescein; Head and Neck Neoplasms; Humans; Male; Middle Aged; Physical Examination; Prospective Studies; Tears; Young Adult | 2023 |
The Effect of Mask Use on the Ocular Surface During the COVID-19 Pandemic.
Topics: COVID-19; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Pandemics; Tears | 2023 |
Morphological and functional assessment of the tear film and meibomian glands in keratoconus.
Topics: Dry Eye Syndromes; Fluorescein; Humans; Keratoconus; Meibomian Gland Dysfunction; Meibomian Glands; Tears | 2023 |
Differentially Expressed Tear Proteins in Sjögren's Syndrome Keratoconjunctivitis Sicca.
Topics: Conjunctiva; Dry Eye Syndromes; Fluorescein; Humans; Keratoconjunctivitis Sicca; Sjogren's Syndrome | 2023 |
Dry eye clinical practice patterns of UK optometrists.
Topics: Dry Eye Syndromes; Fluorescein; Humans; Optometrists; Practice Patterns, Physicians'; United Kingdom | 2023 |
Effects on the Human Tear Film of Applying Skin Lipids to the Ocular Surface.
Topics: Castor Oil; Dry Eye Syndromes; Fluorescein; Humans; Lacerations; Meibomian Glands; Tears | 2023 |
Ocular Surface Changes in Primary Open Angle Glaucoma Patients Treated With Topical Antihypertensive Drugs.
Topics: Antihypertensive Agents; Cross-Sectional Studies; Dry Eye Syndromes; Fluorescein; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lipids; Tears | 2023 |
Effectiveness of rb-bFGF Eye Drops for Post-Cataract Surgery Dry Eye and Observation of Changes in Tear Secretion and Corneal Damage in Patients.
Topics: Animals; Cataract; Cattle; Corneal Injuries; Dry Eye Syndromes; Fluorescein; Humans; Hyaluronic Acid; Ophthalmic Solutions; Quality of Life; Randomized Controlled Trials as Topic; Retrospective Studies | 2023 |
Upregulation of the IL-33/ST2 pathway in dry eye.
Topics: Adult; Dry Eye Syndromes; Epithelial Cells; Female; Fluorescein; Humans; Interleukin-1 Receptor-Like 1 Protein; Interleukin-33; Male; Middle Aged; Reproducibility of Results; Signal Transduction; Tears; Up-Regulation | 2019 |
Cyclosporine A eyedrops with self-nanoemulsifying drug delivery systems have improved physicochemical properties and efficacy against dry eye disease in a murine dry eye model.
Topics: Animals; Apoptosis; Cell Count; Conjunctiva; Cyclosporine; Cytokines; Disease Models, Animal; Drug Delivery Systems; Dry Eye Syndromes; Emulsions; Epithelium, Corneal; Fluorescein; Goblet Cells; Hydrogen-Ion Concentration; Inflammation; Ki-67 Antigen; Mice; Nanoparticles; Nephelometry and Turbidimetry; Ophthalmic Solutions; Particle Size; Tears; Treatment Outcome; Viscosity | 2019 |
Characteristics of tear abnormalities associated with benign essential blepharospasm and amelioration by means of botulinum toxin type A treatment.
Topics: Adult; Aged; Aged, 80 and over; Blepharospasm; Botulinum Toxins, Type A; Cross-Sectional Studies; Dry Eye Syndromes; Female; Fluorescein; Humans; Injections, Intramuscular; Male; Middle Aged; Neuromuscular Agents; Prospective Studies; Quality of Life; Staining and Labeling; Surveys and Questionnaires; Tears; Wettability | 2020 |
Effects of radiation therapy on the meibomian glands and dry eye in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma.
Topics: Adult; Aged; Conjunctival Neoplasms; Dry Eye Syndromes; Eye Neoplasms; Female; Fluorescein; Fluorescent Dyes; Humans; Lacrimal Apparatus Diseases; Lymphoma, B-Cell, Marginal Zone; Male; Meibomian Glands; Middle Aged; Orbital Neoplasms; Prospective Studies; Radiation Injuries; Radiotherapy, Intensity-Modulated; Slit Lamp Microscopy; Surveys and Questionnaires; Tears; Young Adult | 2020 |
Endocrine disrupting chemicals associated with dry eye syndrome.
Topics: Dry Eye Syndromes; Endocrine Disruptors; Female; Fluorescein; Humans; Surveys and Questionnaires; Tears | 2020 |
Agreement and repeatability of four different devices to measure non-invasive tear breakup time (NIBUT).
Topics: Cross-Sectional Studies; Dry Eye Syndromes; Fluorescein; Humans; Tears; Vision Tests | 2020 |
The effect of sodium fluorescein on anterior eye surface measurements.
Topics: Adult; Australia; Cornea; Corneal Topography; Dry Eye Syndromes; Fluorescein; Humans; Middle Aged; Prospective Studies; Reproducibility of Results; Tears; Young Adult | 2020 |
Dry Eye Disease Practice in Ghana: Diagnostic Perspectives, Treatment Modalities, and Challenges.
Topics: Adult; Cyclosporine; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Ghana; Humans; Immunosuppressive Agents; Lubricant Eye Drops; Male; Middle Aged; Optometrists; Osmolar Concentration; Practice Patterns, Physicians'; Punctal Plugs; Serum; Surveys and Questionnaires; Tears; Treatment Outcome; Young Adult | 2020 |
Normalized ocular surface temperature models for tear film characteristics and dry eye disease evaluation.
Topics: Blinking; Dry Eye Syndromes; Fluorescein; Humans; Tears; Temperature | 2021 |
Optimal methodology for lid wiper epitheliopathy identification.
Topics: Conjunctiva; Dry Eye Syndromes; Eyelids; Fluorescein; Humans; Staining and Labeling | 2021 |
Parameter Estimation for Evaporation-Driven Tear Film Thinning.
Topics: Computational Biology; Computer Simulation; Dry Eye Syndromes; Fluorescein; Fluorescent Dyes; Fluorophotometry; Humans; Hydrodynamics; Least-Squares Analysis; Mathematical Concepts; Models, Biological; Nonlinear Dynamics; Osmolar Concentration; Tears | 2020 |
Clinical Manifestation and Risk Factors Associated With Remission in Patients With Filamentary Keratitis.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Brain Diseases; Child; Dry Eye Syndromes; Eye Injuries; Female; Fluorescein; Follow-Up Studies; Free Radical Scavengers; Humans; Keratitis; Male; Middle Aged; Ophthalmologic Surgical Procedures; Remission Induction; Retrospective Studies; Risk Factors; Serum; Slit Lamp Microscopy | 2020 |
Association of the Indoor Environment With Dry Eye Metrics.
Topics: Aged; Air Pollution, Indoor; Benchmarking; Cross-Sectional Studies; Dry Eye Syndromes; Environmental Monitoring; Female; Fluorescein; Fluorescent Dyes; Humans; Humidity; Male; Middle Aged; Particulate Matter; Prospective Studies; Surveys and Questionnaires; Tears; Temperature; United States; Veterans | 2020 |
In Vivo Confocal Microscopy Morphometric Analysis of Meibomian Glands in Patients With Graves Ophthalmopathy.
Topics: Adult; Case-Control Studies; Cell Count; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Graves Ophthalmopathy; Humans; Male; Meibomian Gland Dysfunction; Meibomian Glands; Microscopy, Confocal; Middle Aged; Slit Lamp Microscopy; Staining and Labeling; Tears | 2021 |
Long-Term Exposure to Urban Particulate Matter on the Ocular Surface and the Incidence of Deleterious Changes in the Cornea, Conjunctiva and Retina in Rats.
Topics: Animals; Cell Line; Conjunctiva; Cornea; Disease Models, Animal; Dry Eye Syndromes; Epithelium, Corneal; Fluorescein; Humans; Incidence; Interleukin-6; Male; Particulate Matter; Rats; Rats, Sprague-Dawley; Retina; Tears | 2020 |
Evaluation of Dry Eye after Implantable Collamer Lens Surgery.
Topics: Dry Eye Syndromes; Fluorescein; Humans; Lenses, Intraocular; Meibomian Glands; Prospective Studies; Tears | 2021 |
Changes in Corneal Subbasal Nerves after Punctal Occlusion in Dry Eye Disease.
Topics: Adult; Cornea; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Microscopy, Confocal; Middle Aged; Nasolacrimal Duct; Ophthalmic Nerve; Prospective Studies; Punctal Plugs; Rose Bengal; Sensation; Surveys and Questionnaires; Tears | 2021 |
Easy and effective test to evaluate tear-film stability for self-diagnosis of dry eye syndrome: blinking tolerance time (BTT).
Topics: Blinking; Dry Eye Syndromes; Fluorescein; Humans; Prospective Studies; Tears | 2020 |
Strip Meniscometry Correlates With Ocular Surface Tests and Symptoms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Cross-Sectional Studies; Dry Eye Syndromes; Eye; Female; Fluorescein; Humans; Male; Middle Aged; Tears; Young Adult | 2020 |
Inter-week variation of meibometry and tear break-up time in healthy subjects.
Topics: Blinking; Dry Eye Syndromes; Fluorescein; Healthy Volunteers; Humans; Tears | 2021 |
Applying a dual-Scheimpflug camera to measure tear film thickness.
Topics: Adult; Cornea; Dry Eye Syndromes; Fluorescein; Humans; Middle Aged; Prospective Studies; Tears; Young Adult | 2022 |
Evaluation of dry eye disease in children with blepharokeratoconjunctivitis.
Topics: Canada; Child; Conjunctiva; Dry Eye Syndromes; Fluorescein; Humans; Tears | 2022 |
Clinicopathologic analysis of conjunctivochalasis and paste-pinch-cut conjunctivoplasty for management.
Topics: Conjunctiva; Conjunctival Diseases; Dry Eye Syndromes; Fluorescein; Humans; Inflammation; Retrospective Studies; Tears | 2022 |
The role of meibomian gland dysfunction on the development of dry eye disease in patients with facial nerve palsy.
Topics: Dry Eye Syndromes; Eyelid Diseases; Facial Nerve; Fluorescein; Humans; Meibomian Gland Dysfunction; Meibomian Glands; Paralysis; Tears | 2021 |
Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease.
Topics: Aged; Biomarkers; Case-Control Studies; Conjunctiva; Cornea; Cytokines; Dry Eye Syndromes; Female; Fluorescein; Humans; Interleukin-17; Interleukin-23; Interleukin-6; Middle Aged; RNA, Messenger; Sjogren's Syndrome; Tears; Th17 Cells | 2017 |
Qualitative assessment of tear dynamics with fluorescein profilometry.
Topics: Adult; Aged; Blinking; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Healthy Volunteers; Humans; Male; Middle Aged; Tears; Young Adult | 2017 |
Effects of Diquafosol Ophthalmic Solution on Quality of Life in Dry Eye Assessed Using the Dry Eye-Related Quality-of-Life Score Questionnaire: Effectiveness in Patients While Reading and Using Visual Display Terminals.
Topics: Activities of Daily Living; Computer Terminals; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Lubricant Eye Drops; Male; Middle Aged; Ophthalmic Solutions; Polyphosphates; Purinergic P2Y Receptor Agonists; Quality of Life; Reading; Staining and Labeling; Surveys and Questionnaires; Tears; Tomography, Optical Coherence; Treatment Outcome; Uracil Nucleotides | 2017 |
Classification of Fluorescein Breakup Patterns: A Novel Method of Differential Diagnosis for Dry Eye.
Topics: Aged; Cross-Sectional Studies; Diagnosis, Differential; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Fluorophotometry; Humans; Male; Middle Aged; Surveys and Questionnaires; Tears | 2017 |
Tear film and ocular surface assessment in psoriasis.
Topics: Adult; Aged; Conjunctiva; Cornea; Cross-Sectional Studies; Dry Eye Syndromes; Eyelid Diseases; Female; Fluorescein; Fluorescent Dyes; Fluorophotometry; Humans; Male; Meibomian Glands; Middle Aged; Psoriasis; Surveys and Questionnaires; Tears | 2018 |
Evaluating Corneal Fluorescein Staining Using a Novel Automated Method.
Topics: Analysis of Variance; Corneal Diseases; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Epithelium, Corneal; Fluorescein; Fluorescent Dyes; Humans; Image Processing, Computer-Assisted; Observer Variation; Prospective Studies; Reproducibility of Results | 2017 |
Monocarboxylate Transporters Mediate Fluorescein Uptake in Corneal Epithelial Cells.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Acute Disease; Animals; Biological Transport; Cells, Cultured; Dose-Response Relationship, Drug; Dry Eye Syndromes; Epithelium, Corneal; Fluorescein; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Immunohistochemistry; Microscopy, Fluorescence; Monocarboxylic Acid Transporters; Muscle Proteins; Rabbits; Real-Time Polymerase Chain Reaction; Salicylates; Symporters | 2017 |
Evaluating tear clearance rate with optical coherence tomography.
Topics: Adult; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Lacrimal Apparatus; Male; Slit Lamp Microscopy; Tears; Tomography, Optical Coherence; Young Adult | 2018 |
Dry eye disease in the elderly in a French population-based study (the Montrachet study: Maculopathy, Optic Nerve, nuTRition, neurovAsCular and HEarT diseases): Prevalence and associated factors.
Topics: Aged; Aged, 80 and over; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; France; Humans; Male; Prevalence; Risk Factors; Staining and Labeling; Surveys and Questionnaires; Tears; Visual Acuity | 2018 |
Computed flow and fluorescence over the ocular surface.
Topics: Computer Simulation; Dry Eye Syndromes; Eye; Fluorescein; Fluorescence; Humans; Mathematical Concepts; Models, Biological; Osmolar Concentration; Permeability; Tears; Video Recording | 2018 |
Micro-instillation of fluorescein with an inoculation loop for ocular surface staining in dry eye syndrome.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Conjunctiva; Cornea; Drug Delivery Systems; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Staining and Labeling | 2018 |
Tear-Film Evaporation Rate from Simultaneous Ocular-Surface Temperature and Tear-Breakup Area.
Topics: Body Temperature; Cornea; Dry Eye Syndromes; Fluorescein; Humans; Lipids; Ocular Physiological Phenomena; Tears; Video Recording; Volatilization | 2018 |
Dry Eye Assessment in Patients With Vitiligo.
Topics: Adult; Aged; Case-Control Studies; Cornea; Cross-Sectional Studies; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Osmolar Concentration; Tears; Vitiligo | 2018 |
Survey of Ophthalmologists Regarding Practice Patterns for Dry Eye and Sjogren Syndrome.
Topics: Adult; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Ophthalmologists; Practice Patterns, Physicians'; Referral and Consultation; Sjogren's Syndrome; Staining and Labeling; Tears | 2018 |
[Autologous serum tears: Long-term treatment in dry eye syndrome].
Topics: Adult; Aged; Aged, 80 and over; Dry Eye Syndromes; Female; Fluorescein; Follow-Up Studies; Graft vs Host Disease; Humans; Lubricant Eye Drops; Male; Middle Aged; Preservation, Biological; Retrospective Studies; Serum; Severity of Illness Index; Sjogren's Syndrome; Surface Tension; Tears | 2018 |
Tear film evaluation by scanning laser ophthalmoscopy during retinal imaging.
Topics: Adult; Aged; Aged, 80 and over; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Microscopy, Confocal; Middle Aged; Ophthalmoscopy; Retina; Tears | 2018 |
Prevalence and clinical characteristics of dry eye disease in community-based type 2 diabetic patients: the Beixinjing eye study.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; China; Cornea; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Prevalence; Risk Factors; Tears | 2018 |
Corneal fluorescein staining and ocular symptoms but not Schirmer test are useful as indicators of response to treatment in chronic ocular GVHD.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Bacterial Agents; Chronic Disease; Diagnostic Techniques, Ophthalmological; Disease Progression; Dry Eye Syndromes; Female; Fluorescein; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Predictive Value of Tests; Regression Analysis; Retrospective Studies; Young Adult | 2018 |
Topical Quercetin and Resveratrol Protect the Ocular Surface in Experimental Dry Eye Disease.
Topics: Administration, Ophthalmic; Animals; Antioxidants; CD4-Positive T-Lymphocytes; Conjunctiva; Cornea; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Mice; Mice, Inbred C57BL; Mice, Nude; Quercetin; Resveratrol; Staining and Labeling; Tears | 2019 |
An Automated Grading and Diagnosis System for Evaluation of Dry Eye Syndrome.
Topics: Cornea; Dry Eye Syndromes; Female; Fluorescein; Fluorophotometry; Health Status Indicators; Humans; Male | 2018 |
Dynamics of Fluorescent Imaging for Rapid Tear Thinning.
Topics: Computer Simulation; Dry Eye Syndromes; Fluorescein; Fluorescent Dyes; Humans; Lipid Metabolism; Mathematical Concepts; Models, Biological; Optical Imaging; Osmolar Concentration; Surface Tension; Surface-Active Agents; Tears | 2019 |
Comparative performance of lid wiper epitheliopathy and corneal staining in detecting dry eye disease.
Topics: Adult; Coloring Agents; Cornea; Dry Eye Syndromes; Epithelial Cells; Eyelids; Female; Fluorescein; Fluorescent Dyes; Humans; Lissamine Green Dyes; Male; Middle Aged; Predictive Value of Tests; Sensitivity and Specificity; Staining and Labeling; Surveys and Questionnaires | 2019 |
Spontaneous Eye Blink Patterns in Dry Eye: Clinical Correlations.
Topics: Adult; Aged; Blinking; Case-Control Studies; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Lipid Metabolism; Male; Middle Aged; Prospective Studies; Tears; Young Adult | 2018 |
Association Between Sleep Quality, Mood Status, and Ocular Surface Characteristics in Patients With Dry Eye Disease.
Topics: Adult; Aged; Anxiety; Case-Control Studies; Cornea; Depression; Dry Eye Syndromes; Female; Fluorescein; Health Status; Humans; Male; Meibomian Glands; Middle Aged; Severity of Illness Index; Sleep; Tears; Vision, Ocular | 2019 |
Comparative study of tear lipid composition in two human populations with different exposure to particulate matter in La Plata, Argentina.
Topics: Adult; Air Pollution; Argentina; Conjunctiva; Dry Eye Syndromes; Environmental Exposure; Fatty Acids, Omega-6; Female; Fluorescein; Humans; Lipids; Male; Middle Aged; Particulate Matter; Tears | 2019 |
Modulation of Inflammation-Related Genes in the Cornea of a Mouse Model of Dry Eye upon Treatment with Cyclosporine Eye Drops.
Topics: Administration, Ophthalmic; Animals; Cornea; Cyclosporine; Cytokines; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Gene Expression Regulation; Genetic Markers; Immunosuppressive Agents; Inflammation; Mice; Mice, Inbred C57BL; Ophthalmic Solutions; Receptors, Cytokine; RNA, Messenger; Tears | 2019 |
Effect of TMAO, a Gut-Bacteria Metabolite, on Dry Eye in a Rat Model.
Topics: Administration, Ophthalmic; Animals; Blinking; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescein; Methylamines; Ophthalmic Solutions; Oxidants; Rats; Rats, Sprague-Dawley; Staining and Labeling | 2019 |
Age-Related Conjunctival P2Y2 Receptor Alterations in the Cu, Zn-Superoxide Dismutase-1 (Sod1)-Knockout Dry Eye Model Mice.
Topics: Aging; Animals; Conjunctiva; Cornea; Disease Models, Animal; Dry Eye Syndromes; Fluorescein; Gene Expression Regulation; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Purinergic P2Y2; RNA, Messenger; Superoxide Dismutase-1; Tears | 2019 |
Inferior Quadrant of Tear Film Is More Likely to Break and Breaks Early in Patients With Dry Eyes.
Topics: Adult; Case-Control Studies; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; ROC Curve; Tears; Young Adult | 2019 |
Evaluation of Dry Eye Disease in Children With Systemic Lupus Erythematosus and Healthy Controls.
Topics: Adolescent; Canada; Case-Control Studies; Child; Cornea; Dry Eye Syndromes; Female; Fluorescein; Fluorophotometry; Humans; Lupus Erythematosus, Systemic; Male; Osmolar Concentration; Pilot Projects; Prospective Studies; Slit Lamp Microscopy; Tears | 2019 |
Lower Tear Meniscus Height Measurements Using Keratography and Swept-Source Optical Coherence Tomography and Effect of Fluorescein Instillation Methods.
Topics: Adolescent; Adult; China; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Reference Values; Reproducibility of Results; Staining and Labeling; Tears; Tomography, Optical Coherence; Young Adult | 2019 |
Short-Term Effects of Ground-Level Ozone in Patients With Dry Eye Disease: A Prospective Clinical Study.
Topics: Adult; Aged; Cornea; Cross-Sectional Studies; Cyclosporine; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Immunosuppressive Agents; Male; Middle Aged; Ophthalmic Solutions; Oxidants, Photochemical; Ozone; Polyphosphates; Prospective Studies; Tears; Uracil Nucleotides | 2019 |
Geographic distribution of corneal staining in symptomatic dry eye.
Topics: Bayes Theorem; Cornea; Dry Eye Syndromes; Fluorescein; Humans; Staining and Labeling | 2020 |
Comprehensive Clinical, Diagnostic, and Advanced Imaging Characterization of the Ocular Surface in Spontaneous Aqueous Deficient Dry Eye Disease in Dogs.
Topics: Animals; Aqueous Humor; Coloring Agents; Cornea; Corneal Pachymetry; Dog Diseases; Dogs; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Keratoconjunctivitis Sicca; Lissamine Green Dyes; Male; Meibomian Glands; Osmolar Concentration; Rose Bengal; Slit Lamp Microscopy; Tears; Tomography, Optical Coherence | 2019 |
Evaluation of Corneal Damage After Lacrimal Gland Excision in Male and Female Mice.
Topics: Animals; Corneal Diseases; Dry Eye Syndromes; Female; Flow Cytometry; Fluorescein; Fluorescent Dyes; In Situ Nick-End Labeling; Inflammation; Ki-67 Antigen; Lacrimal Apparatus; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Sex Factors; Tears | 2019 |
Investigation of capsaicin-induced superficial punctate keratopathy model due to reduced tear secretion in rats.
Topics: Animals; Capsaicin; Corneal Diseases; Disease Models, Animal; Dose-Response Relationship, Drug; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Injections, Subcutaneous; Lacrimal Apparatus; Miotics; Pilocarpine; Pupil; Rats; Rats, Wistar; Sensory System Agents; Tears | 2013 |
Factors predicting the ocular surface response to desiccating environmental stress.
Topics: Adult; Blinking; Conjunctiva; Cornea; Desiccation; Dry Eye Syndromes; Eye Protective Devices; Female; Fluorescein; Humans; Lissamine Green Dyes; Male; Middle Aged; Staining and Labeling; Stress, Physiological; Surveys and Questionnaires; Tears | 2013 |
Long-term results of treatment with diquafosol ophthalmic solution for aqueous-deficient dry eye.
Topics: Aged; Conjunctiva; Cornea; Dry Eye Syndromes; Female; Fluorescein; Fluorometry; Follow-Up Studies; Humans; Male; Middle Aged; Ophthalmic Solutions; Polyphosphates; Purinergic P2Y Receptor Agonists; Tears; Tomography, Optical Coherence; Treatment Outcome; Uracil Nucleotides | 2013 |
Comparison on the vision-related quality of life between outpatients and general population with dry eye syndrome.
Topics: Adolescent; Adult; Aged; Cross-Sectional Studies; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Fluorophotometry; Healthy Volunteers; Humans; Male; Middle Aged; Outpatients; Quality of Life; Sickness Impact Profile; Staining and Labeling; Surveys and Questionnaires; Tears; Vision, Ocular; Visual Acuity; Young Adult | 2014 |
Prevalence of dry eye syndrome in an adult population.
Topics: Adult; Age Distribution; Cornea; Cross-Sectional Studies; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Iran; Male; Middle Aged; Prevalence; Rose Bengal; Sex Distribution; Sex Factors; Staining and Labeling | 2014 |
What is the value of incorporating tear osmolarity measurement in assessing patient response to therapy in dry eye disease?
Topics: Antirheumatic Agents; Blood; Cornea; Cyclosporine; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Fluorophotometry; Glucocorticoids; Humans; Immunosuppressive Agents; Interleukin 1 Receptor Antagonist Protein; Lubricants; Male; Middle Aged; Ophthalmic Solutions; Osmolar Concentration; Retrospective Studies; Surveys and Questionnaires; Tears | 2014 |
Establishment of the mild, moderate and severe dry eye models using three methods in rabbits.
Topics: Animals; Burns, Chemical; Cell Count; Conjunctiva; Cornea; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescein; Goblet Cells; Harderian Gland; Lacrimal Apparatus; Rabbits; Tears; Trichloroacetic Acid | 2013 |
Fluorescein: its use in investigation of lacrimal characteristics.
Topics: Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Fluorescein; Fluorescent Dyes; History, 18th Century; History, 19th Century; History, 20th Century; Humans; Reagent Strips; Staining and Labeling; Tears | 2013 |
Comparison of dry eye and corneal sensitivity between small incision lenticule extraction and femtosecond LASIK for myopia.
Topics: Adult; Case-Control Studies; Cornea; Dry Eye Syndromes; Female; Fluorescein; Follow-Up Studies; Humans; Keratomileusis, Laser In Situ; Lasers, Excimer; Male; Myopia; Prognosis; Prospective Studies; Sensation; Surgical Flaps | 2013 |
An evidence-based analysis of Australian optometrists' dry eye practices.
Topics: Adult; Australia; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Evidence-Based Medicine; Fluorescein; Health Surveys; Humans; Meibomian Glands; Optometry; Osmolar Concentration; Practice Patterns, Physicians'; Surveys and Questionnaires; Tears | 2013 |
The value of tear osmolarity as a metric in evaluating the response to dry eye therapy in the clinic and in clinical trials.
Topics: Cornea; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Tears | 2014 |
Corneal staining characteristics in limited zones compared with whole cornea documentation for the detection of dry eye subtypes.
Topics: Cornea; Documentation; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Staining and Labeling | 2013 |
A multicenter, open-label, 52-week study of 2% rebamipide (OPC-12759) ophthalmic suspension in patients with dry eye.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Antioxidants; Cornea; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Quinolones; Staining and Labeling; Suspensions; Tears; Time Factors; Treatment Outcome; Visual Acuity; Young Adult | 2014 |
The influence of benign essential blepharospasm on dry eye disease and ocular inflammation.
Topics: Blepharospasm; Botulinum Toxins, Type A; Conjunctiva; Cytokines; Dry Eye Syndromes; Female; Fluorescein; Humans; Immunoassay; Inflammation; Male; Middle Aged; Neuromuscular Agents; Prospective Studies; Staining and Labeling; Surveys and Questionnaires; Tears | 2014 |
Basal values, intra-day and inter-day variations in tear film osmolarity and tear fluorescein clearance.
Topics: Adolescent; Adult; Circadian Rhythm; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Fluorophotometry; Follow-Up Studies; Healthy Volunteers; Humans; Male; Ophthalmic Solutions; Osmolar Concentration; Prospective Studies; Reproducibility of Results; Tears; Young Adult | 2014 |
Dry eye exacerbation in patients exposed to desiccating stress under controlled environmental conditions.
Topics: Coloring Agents; Conjunctiva; Cornea; Cross-Sectional Studies; Dry Eye Syndromes; Environment, Controlled; Eye Proteins; Female; Fluorescein; Fluorescent Dyes; Humans; Humidity; Male; Middle Aged; Osmolar Concentration; Phenolsulfonphthalein; Prospective Studies; Stress, Physiological; Surveys and Questionnaires; Tears | 2014 |
Analysis of parameters for the automatic computation of the tear film break-up time test based on CCLRU standards.
Topics: Adult; Algorithms; Computational Biology; Databases, Factual; Diagnosis, Computer-Assisted; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Fluorescein; Fluorescent Dyes; Humans; Microscopy, Fluorescence; Microscopy, Video; Tears; Young Adult | 2014 |
Reliability of 4 clinical grading systems for corneal staining.
Topics: Corneal Diseases; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Epithelium, Corneal; Fluorescein; Fluorescent Dyes; Humans; Keratoconjunctivitis; Observer Variation; Reproducibility of Results; Retrospective Studies; Staining and Labeling | 2014 |
A novel nanoscale-dispersed eye ointment for the treatment of dry eye disease.
Topics: Animals; Disease Models, Animal; Dry Eye Syndromes; Emulsions; Epithelial Cells; Fluorescein; Humans; Lanolin; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Nanoparticles; Ointments; Ophthalmic Solutions; Petrolatum; Triglycerides | 2014 |
A new nonhuman primate model of severe dry eye.
Topics: Animals; Caustics; Conjunctiva; Cornea; Disease Models, Animal; Dry Eye Syndromes; Fluorescein; Fluorophotometry; Goblet Cells; Lacrimal Apparatus; Macaca mulatta; Male; Metaplasia; Tears; Trichloroacetic Acid | 2014 |
The value of tear osmolarity as a metric in evaluating the response to dry eye therapy in the clinic and in clinical trials.
Topics: Cornea; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Tears | 2014 |
Tear film osmolarity in ocular mucous membrane pemphigoid.
Topics: Aged; Conjunctiva; Cornea; Cross-Sectional Studies; Dry Eye Syndromes; Female; Fluorescein; Humans; Immunosuppressive Agents; Lissamine Green Dyes; Male; Osmolar Concentration; Pemphigoid, Benign Mucous Membrane; Surveys and Questionnaires; Tears | 2014 |
Effects of androgen on ultrastructure of corneal epithelium and function of the tear film in BALB/c mice.
Topics: Androgens; Animals; Cornea; Dihydrotestosterone; Disease Models, Animal; Dry Eye Syndromes; Epithelium, Corneal; Fluorescein; Male; Mice; Mice, Inbred BALB C; Microvilli; Orchiectomy; Random Allocation; Tears | 2015 |
Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.
Topics: Administration, Topical; Aged; Alanine; Drug Therapy, Combination; Dry Eye Syndromes; Enzyme Inhibitors; Female; Fluorescein; Fluorescent Dyes; Follow-Up Studies; Graft vs Host Disease; Humans; Middle Aged; Ophthalmic Solutions; Pemphigoid, Benign Mucous Membrane; Polyphosphates; Purinergic P2Y Receptor Agonists; Quinolones; Treatment Outcome; Uracil Nucleotides; Visual Acuity | 2015 |
Evaluation of tear malate dehydrogenase 2 in mild dry eye disease.
Topics: Adult; Biomarkers; Case-Control Studies; Dry Eye Syndromes; Female; Fluorescein; Humans; Malate Dehydrogenase; Male; Middle Aged; Ophthalmic Solutions; Slit Lamp; Surveys and Questionnaires; Tears | 2014 |
Effectiveness and relevant factors of 2% rebamipide ophthalmic suspension treatment in dry eye.
Topics: Aged; Alanine; Antioxidants; Cornea; Dry Eye Syndromes; Enzyme Inhibitors; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Ophthalmic Solutions; Quinolones; Retrospective Studies; Suspensions | 2015 |
Automated Grading System for Evaluation of Superficial Punctate Keratitis Associated With Dry Eye.
Topics: Cornea; Diagnosis, Computer-Assisted; Dry Eye Syndromes; Fluorescein; Fluorescent Dyes; Humans; Keratoconjunctivitis Sicca; Reproducibility of Results; Software; Staining and Labeling | 2015 |
Correlation of Dry Eye Workshop Dry Eye Severity Grading System With Tear Meniscus Measurement by Optical Coherence Tomography and Tear Osmolarity.
Topics: Adult; Aged; Coloring Agents; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Fluorophotometry; Fourier Analysis; Humans; Lissamine Green Dyes; Male; Middle Aged; Osmolar Concentration; Prospective Studies; Severity of Illness Index; Tears; Tomography, Optical Coherence | 2016 |
Efficacy and Safety of Topical Atorvastatin for the Treatment of Dry Eye Associated with Blepharitis: A Pilot Study.
Topics: Aged; Aged, 80 and over; Atorvastatin; Blepharitis; Dry Eye Syndromes; Female; Fluorescein; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Male; Middle Aged; Ophthalmic Solutions; Pilot Projects; Prospective Studies; Tears | 2015 |
Correlation Between Tear Film Osmolarity and the Disease Score of the International Chronic Ocular Graft-Versus-Host-Disease Consensus Group in Hematopoietic Stem Cell Transplantation Patients.
Topics: Adult; Chronic Disease; Cornea; Cross-Sectional Studies; Dry Eye Syndromes; Female; Fluorescein; Fluorophotometry; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Lymphoma; Male; Middle Aged; Osmolar Concentration; Prospective Studies; ROC Curve; Sensitivity and Specificity; Severity of Illness Index; Staining and Labeling; Surveys and Questionnaires; Tears; Transplantation, Homologous | 2015 |
The course of dry eye after phacoemulsification surgery.
Topics: Aged; Aged, 80 and over; Chronic Disease; Cyclosporine; Dry Eye Syndromes; Female; Fluorescein; Fluorophotometry; Humans; Immunosuppressive Agents; Lubricant Eye Drops; Male; Middle Aged; Phacoemulsification; Retrospective Studies; Staining and Labeling; Tears | 2015 |
The Effects of Increasing Ocular Surface Stimulation on Blinking and Tear Secretion.
Topics: Adult; Air; Blinking; Cornea; Dry Eye Syndromes; Female; Fluorescein; Healthy Volunteers; Humans; Male; Models, Theoretical; Physical Stimulation; Sensation; Tears; Young Adult | 2015 |
Ocular findings in alopecia areata.
Topics: Adult; Alopecia Areata; Autoimmune Diseases; Case-Control Studies; Coloring Agents; Cornea; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Surveys and Questionnaires; T-Lymphocytes; Tears; Young Adult | 2015 |
Relationships among Tear Film Stability, Osmolarity, and Dryness Symptoms.
Topics: Adolescent; Adult; Aged; Contact Lenses, Hydrophilic; Cross-Sectional Studies; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Osmolar Concentration; Sensitivity and Specificity; Tears; Young Adult | 2015 |
Influence of Eyelid Pressure on Fluorescein Staining of Ocular Surface in Dry Eyes.
Topics: Adult; Aged; Aged, 80 and over; Blinking; Conjunctiva; Cornea; Cross-Sectional Studies; Dry Eye Syndromes; Eyelids; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Manometry; Middle Aged; Pressure; Prospective Studies; Staining and Labeling; Young Adult | 2015 |
Effectiveness of Autologous Serum Eye Drops Combined With Punctal Plugs for the Treatment of Sjögren Syndrome-Related Dry Eye.
Topics: Adult; Aged; Combined Modality Therapy; Dry Eye Syndromes; Eyelids; Female; Fluorescein; Fluorescent Dyes; Humans; Lacrimal Apparatus; Male; Middle Aged; Ophthalmic Solutions; Prostheses and Implants; Retrospective Studies; Rose Bengal; Serum; Sjogren's Syndrome; Staining and Labeling; Tears; Young Adult | 2015 |
Comparison of conjunctival staining between lissamine green and yellow filtered fluorescein sodium.
Topics: Adult; Coloring Agents; Conjunctiva; Cross-Sectional Studies; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Lissamine Green Dyes; Male; Middle Aged; Retrospective Studies; Staining and Labeling; Young Adult | 2015 |
Reliability of a new modified tear breakup time method: methodological and statistical issues.
Topics: Biometry; Dry Eye Syndromes; Fluorescein; Reproducibility of Results; Tears | 2016 |
Evaluation of a Novel Artificial Tear in the Prevention and Treatment of Dry Eye in an Animal Model.
Topics: Animals; Carboxymethylcellulose Sodium; Conjunctiva; Cornea; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Goblet Cells; Hyaluronic Acid; Lubricant Eye Drops; Mice; Mice, Inbred C57BL; Treatment Outcome | 2015 |
Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.
Topics: Administration, Topical; Animals; Cell Count; Dexamethasone; Disease Models, Animal; Dry Eye Syndromes; Fluorescein; Glucocorticoids; Goblet Cells; Integrin alpha4beta1; Interleukin-1beta; Mice; Mice, Inbred C57BL; Nuclear Receptor Subfamily 1, Group F, Member 3; Ophthalmic Solutions; Phenylalanine; Piperidines; Real-Time Polymerase Chain Reaction; RNA, Messenger; Sjogren's Syndrome; Staining and Labeling; Thrombospondin 1 | 2016 |
Clinical Objective Dry Eye Tests in a Population of Tannery Workers in North India.
Topics: Adult; Cross-Sectional Studies; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Fluorescein; Humans; India; Male; Middle Aged; Occupational Diseases; Severity of Illness Index; Tanning; Tears | 2016 |
Influence of Eyelid Pressure on Fluorescein Staining of Ocular Surface in Dry Eyes.
Topics: Blinking; Dry Eye Syndromes; Eyelids; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Pressure | 2016 |
Reply.
Topics: Blinking; Dry Eye Syndromes; Eyelids; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Pressure | 2016 |
Optimization and validation of an existing, surgical and robust dry eye rat model for the evaluation of therapeutic compounds.
Topics: Animals; Anti-Inflammatory Agents; Conjunctiva; Cyclosporins; Cytokines; Dexamethasone; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescein; Immunohistochemistry; Immunosuppressive Agents; Lacrimal Apparatus; Matrix Metalloproteinase 9; Ophthalmic Solutions; Rats; Rats, Wistar; Tears; Tumor Necrosis Factor-alpha | 2016 |
Effects of Long-term Soft Contact Lenses on Tear Menisci and Corneal Nerve Density.
Topics: Adult; Contact Lenses, Hydrophilic; Cornea; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Fluorophotometry; Humans; Male; Microscopy, Confocal; Refractive Errors; Staining and Labeling; Tears; Tomography, Optical Coherence; Trigeminal Nerve; Young Adult | 2016 |
Size of the Lesions of Superficial Punctate Keratitis in Dry Eye Syndrome Observed With a Slit Lamp.
Topics: Dry Eye Syndromes; Epithelium, Corneal; Fluorescein; Fluorescent Dyes; Humans; Keratitis; Slit Lamp; Staining and Labeling | 2016 |
Corneal permeability changes in dry eye disease: an observational study.
Topics: Adult; Case-Control Studies; Cornea; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Fluorophotometry; Humans; Male; Middle Aged; Permeability | 2016 |
RNA Collection From Human Conjunctival Epithelial Cells Obtained With a New Device for Impression Cytology.
Topics: Adolescent; Adult; Conjunctiva; Cytodiagnosis; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Epithelial Cells; Female; Fluorescein; Humans; Male; Pilot Projects; RNA; Young Adult | 2017 |
Using corneal confocal microscopy to track changes in the corneal layers of dry eye patients after autologous serum treatment.
Topics: Administration, Topical; Cell Count; Cornea; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Microscopy, Confocal; Middle Aged; Ophthalmic Solutions; Prospective Studies; Serum; Treatment Outcome | 2017 |
In vivo confocal microscopy of toxic keratopathy.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Cornea; Corneal Diseases; Cross-Sectional Studies; Dry Eye Syndromes; Epithelium, Corneal; Female; Fluorescein; Humans; Male; Microscopy, Confocal; Middle Aged; Tears; Young Adult | 2017 |
Correlation of vitamin D levels with tear film stability and secretion in patients with dry eye syndrome.
Topics: Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Middle Aged; Retrospective Studies; Surface Properties; Tears; Vitamin D | 2017 |
Direct visualization of aqueous tear secretion from lacrimal gland.
Topics: Administration, Topical; Adult; Conjunctiva; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Lacrimal Apparatus; Male; Middle Aged; Tears; Tomography, Optical Coherence | 2017 |
Evaluation of the Effects of Conjunctivochalasis Excision on Tear Stability and Contrast Sensitivity.
Topics: Aged; Aged, 80 and over; Conjunctiva; Conjunctival Diseases; Contrast Sensitivity; Cornea; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Middle Aged; Prospective Studies; Tears; Treatment Outcome | 2016 |
[Changes in lacrimal secretion in rabbits according to meibomian glands activity].
Topics: Animals; Conjunctiva; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Fluorophotometry; Lacrimal Apparatus; Meibomian Glands; Rabbits; Reproducibility of Results; Sensitivity and Specificity; Tears; Time Factors | 2007 |
Menisci and fullness of the blink in dry eye.
Topics: Adult; Blinking; Dry Eye Syndromes; Female; Fluorescein; Fluorophotometry; Humans; Male; Surveys and Questionnaires; Tears | 2008 |
Evaluation of topical cyclosporine for the treatment of dry eye disease.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Cyclosporine; Drug Evaluation; Dry Eye Syndromes; Female; Fluorescein; Fluorophotometry; Humans; Immunosuppressive Agents; Lissamine Green Dyes; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Tears | 2008 |
Modulation of integrin alpha4beta1 (VLA-4) in dry eye disease.
Topics: Administration, Topical; Animals; CD3 Complex; CD40 Antigens; Chemokine CXCL10; Conjunctiva; Cornea; Cytokines; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescein; Integrin alpha4beta1; Mice; Mice, Inbred C57BL; Oligopeptides; Phenylurea Compounds; Polyethylene Glycols; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2008 |
Inflammatory cytokine expression on the ocular surface in the Botulium toxin B induced murine dry eye model.
Topics: Animals; Botulinum Toxins; Conjunctiva; Cornea; Cytokines; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Antibody Technique; Gene Expression; Lacrimal Apparatus; Mice; Mice, Inbred CBA; Tears | 2009 |
Corneal epithelial opacity in dysfunctional tear syndrome.
Topics: Adult; Case-Control Studies; Conjunctiva; Corneal Opacity; Dry Eye Syndromes; Epithelium, Corneal; Female; Fluorescein; Humans; Lissamine Green Dyes; Male; Microscopy, Confocal; Middle Aged; Prospective Studies; Surveys and Questionnaires; Tears | 2009 |
Clinical assessment of the lower tear meniscus height.
Topics: Contrast Media; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Ophthalmic Solutions; Reference Values; Tears; Young Adult | 2009 |
A novel method for pachymetry mapping of human precorneal tear film using Pentacam with fluorescein.
Topics: Adult; Cornea; Corneal Topography; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Interferometry; Male; Middle Aged; Photography; Prospective Studies; Tears | 2010 |
Dynamic changes in the lower tear meniscus after instillation of artificial tears.
Topics: Adult; Carboxymethylcellulose Sodium; Dry Eye Syndromes; Female; Fluorescein; Fourier Analysis; Humans; Male; Ophthalmic Solutions; Prospective Studies; Tears; Tomography, Optical Coherence | 2010 |
Prevalence of lid wiper epitheliopathy in subjects with dry eye signs and symptoms.
Topics: Adult; Conjunctiva; Dry Eye Syndromes; Epithelium; Eyelids; Fluorescein; Fluorophotometry; Humans; Lissamine Green Dyes; Middle Aged; Prevalence; Surveys and Questionnaires | 2010 |
Polycarbonate membrane impression cytology: evidence for fluorescein staining in normal and dry eye corneas.
Topics: Adult; Cytological Techniques; Dry Eye Syndromes; Epithelium, Corneal; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Polycarboxylate Cement; Staining and Labeling; Young Adult | 2010 |
Association between clinical diagnostic tests and health-related quality of life surveys in patients with dry eye syndrome.
Topics: Adult; Aged; Aged, 80 and over; Cost of Illness; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Middle Aged; Prospective Studies; Quality of Life; Rose Bengal; Sickness Impact Profile; Staining and Labeling; Surveys and Questionnaires; Young Adult | 2010 |
Treatment of ocular graft-versus-host disease with topical cyclosporine 0.05%.
Topics: Administration, Topical; Adolescent; Adult; Aged; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Dry Eye Syndromes; Female; Fluorescein; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lissamine Green Dyes; Male; Middle Aged; Neoplasms; Retrospective Studies; Surveys and Questionnaires; Tears; Treatment Outcome | 2010 |
Predicting dry eye using noninvasive techniques of tear film surface assessment.
Topics: Aberrometry; Adult; Aged; Blinking; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Humans; Interferometry; Lissamine Green Dyes; Male; Middle Aged; ROC Curve; Tears; Young Adult | 2011 |
Interferometry in the evaluation of precorneal tear film thickness in dry eye.
Topics: Adult; Case-Control Studies; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Fluorophotometry; Humans; Interferometry; Lacrimal Apparatus; Light; Male; Middle Aged; Prospective Studies; Reference Values; Rose Bengal; Tears | 2011 |
Tear dynamics and corneal confocal microscopy of subjects with mild self-reported office dry eye.
Topics: Adult; Dry Eye Syndromes; Epithelium, Corneal; Female; Fluorescein; Fluorescent Dyes; Fluorophotometry; Humans; Male; Microscopy, Confocal; Occupations; Prospective Studies; ROC Curve; Self Report; Tears; Tomography, Optical Coherence | 2011 |
Fluorescein punctate staining traced to superficial corneal epithelial cells by impression cytology and confocal microscopy.
Topics: Aged; Aged, 80 and over; Cytological Techniques; Dry Eye Syndromes; Epithelium, Corneal; Eyelid Diseases; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Microscopy, Confocal; Microscopy, Fluorescence; Middle Aged; Mouth Mucosa; Prospective Studies; Staining and Labeling | 2011 |
A mouse dry eye model induced by topical administration of benzalkonium chloride.
Topics: Administration, Topical; Animals; Benzalkonium Compounds; Disease Models, Animal; Dry Eye Syndromes; Fluorescein; In Situ Nick-End Labeling; Inflammation; Male; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Microvilli; Phenolsulfonphthalein; Preservatives, Pharmaceutical; Rose Bengal; Time Factors; Tumor Necrosis Factor-alpha | 2011 |
[Lack of concordance between dry eye syndrome questionnaires and diagnostic tests].
Topics: Aged; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Predictive Value of Tests; Prevalence; Reproducibility of Results; ROC Curve; Rose Bengal; Sensitivity and Specificity; Spain; Staining and Labeling; Surface Tension; Surveys and Questionnaires; Tears | 2011 |
Usefulness of double vital staining with 1% fluorescein and 1% lissamine green in patients with dry eye syndrome.
Topics: Adult; Aged; Coloring Agents; Conjunctiva; Dry Eye Syndromes; Female; Fluorescein; Humans; Lissamine Green Dyes; Male; Middle Aged; Staining and Labeling; Tears | 2011 |
Evaluation of tear stability after surgery for conjunctivochalasis.
Topics: Aged; Aged, 80 and over; Conjunctival Diseases; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Follow-Up Studies; Humans; Male; Middle Aged; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Postoperative Period; Reproducibility of Results; Surface Properties; Surveys and Questionnaires; Tears; Treatment Outcome | 2011 |
The relation of functional visual acuity measurement methodology to tear functions and ocular surface status.
Topics: Adult; Aged; Anesthetics, Local; Blinking; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Procaine; Prospective Studies; Rose Bengal; Tears; Visual Acuity; Young Adult | 2011 |
Tear osmolarity measurements in dry eye related to primary Sjögren's syndrome.
Topics: Adult; Cross-Sectional Studies; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Osmolar Concentration; Sjogren's Syndrome; Staining and Labeling; Tears; Young Adult | 2011 |
A new modified fluorescein strip: Its repeatability and usefulness in tear film break-up time analysis.
Topics: Adult; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Reagent Strips; Reproducibility of Results; Sensitivity and Specificity; Tears | 2012 |
Therapeutic efficacy of topical epigallocatechin gallate in murine dry eye.
Topics: Animals; Antioxidants; Catechin; Chemokines; Cornea; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescein; Immunohistochemistry; Interleukin-1beta; Mice; Mice, Inbred C57BL; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor D | 2011 |
Upper and lower tear menisci in Sjögren's syndrome dry eye.
Topics: Adult; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Follow-Up Studies; Humans; Male; Microscopy, Confocal; Severity of Illness Index; Sjogren's Syndrome; Surface Tension; Tears; Tomography, Optical Coherence | 2011 |
Changes in dry eye diagnostic status following implementation of revised Japanese dry eye diagnostic criteria.
Topics: Adolescent; Adult; Aged; Cross-Sectional Studies; Diagnostic Techniques, Ophthalmological; Disability Evaluation; Dry Eye Syndromes; Female; Fluorescein; Guideline Adherence; Humans; Japan; Male; Middle Aged; Practice Guidelines as Topic; Rose Bengal; Sickness Impact Profile; Surveys and Questionnaires; Tears; Young Adult | 2012 |
Corneal fluorescein staining correlates with visual function in dry eye patients.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Coloring Agents; Corneal Diseases; Corneal Topography; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Prospective Studies; Sjogren's Syndrome; Tears; Visual Acuity | 2011 |
Development of the 4-3-2-1 meibum expressibility scale.
Topics: Aged; Case-Control Studies; Conjunctiva; Cornea; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Humans; Lipid Metabolism; Lissamine Green Dyes; Male; Meibomian Glands; Middle Aged; Osmolar Concentration; Pilot Projects; Severity of Illness Index; Surveys and Questionnaires; Tears | 2012 |
Visual function changes after punctal occlusion with the treatment of short BUT type of dry eye.
Topics: Adult; Aged; Aged, 80 and over; Dry Eye Syndromes; Eyelids; Female; Fluorescein; Fluorescent Dyes; Humans; Lacrimal Apparatus; Male; Middle Aged; Patient Satisfaction; Prospective Studies; Prostheses and Implants; Prosthesis Implantation; Quality of Life; Surveys and Questionnaires; Tears; Visual Acuity; Young Adult | 2012 |
Correlation between optical coherence tomography-derived assessments of lower tear meniscus parameters and clinical features of dry eye disease.
Topics: Adult; Aged; Aged, 80 and over; Cornea; Dry Eye Syndromes; Eyelids; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Middle Aged; Prospective Studies; Rose Bengal; Surveys and Questionnaires; Tears; Tomography, Optical Coherence; Young Adult | 2012 |
Ocular surface changes in eyes with glaucoma filtering blebs.
Topics: Cornea; Disease Progression; Dry Eye Syndromes; Filtering Surgery; Fluorescein; Fluorescent Dyes; Glaucoma; Humans; Middle Aged; Prognosis; Rose Bengal; Surface Properties; Tears | 2012 |
Effect of topically applied epithelial sodium channel inhibitors on tear production in normal mice and in mice with induced aqueous tear deficiency.
Topics: Administration, Topical; Amiloride; Animals; Coloring Agents; Diuretics; Dogs; Dry Eye Syndromes; Epithelial Sodium Channels; Female; Fluorescein; Mice; Mice, Inbred BALB C; Purinergic P1 Receptor Antagonists; Sodium Channel Blockers; Tears; Uridine Triphosphate | 2012 |
Item by item analysis strategy of the relationship between symptoms and signs in early dry eye.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cornea; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Early Diagnosis; Female; Fluorescein; Fluorescent Dyes; Follow-Up Studies; Humans; Male; Microscopy, Phase-Contrast; Middle Aged; Ophthalmic Solutions; Osmolar Concentration; Predictive Value of Tests; Reproducibility of Results; ROC Curve; Surveys and Questionnaires; Tears; Time Factors; Young Adult | 2012 |
Children with dry eye type conditions may report less severe symptoms than adult patients.
Topics: Case-Control Studies; Child; Conjunctival Diseases; Corneal Diseases; Dry Eye Syndromes; Eyelid Diseases; Female; Fluorescein; Fluorescent Dyes; Fluorophotometry; Humans; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Staining and Labeling; Surveys and Questionnaires; Tears | 2013 |
Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Botulinum Toxins; Botulinum Toxins, Type A; Conjunctiva; Cornea; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescein; Fluorometholone; Glucocorticoids; Interleukin-1beta; Ketorolac; Lacrimal Apparatus; Mice; Mice, Inbred CBA; Ophthalmic Solutions; Phenylacetates; Tears; Tumor Necrosis Factor-alpha | 2012 |
Lid margins: sensitivity, staining, meibomian gland dysfunction, and symptoms.
Topics: Adult; Dry Eye Syndromes; Eyelid Diseases; Eyelids; Female; Fluorescein; Fluorescent Dyes; Follow-Up Studies; Humans; Male; Meibomian Glands; Middle Aged; Pilot Projects; Prospective Studies; Staining and Labeling; Surveys and Questionnaires; Young Adult | 2012 |
Lid-parallel conjunctival folds (LIPCOF) and dry eye: a multicentre study.
Topics: Conjunctiva; Diagnosis, Differential; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Follow-Up Studies; Humans; Male; Middle Aged; Severity of Illness Index; Tears | 2012 |
Ocular surface disease and glaucoma: how to evaluate impact on quality of life.
Topics: Administration, Ophthalmic; Age Factors; Aged; Aged, 80 and over; Benzalkonium Compounds; Cross-Sectional Studies; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Keratitis; Male; Middle Aged; Ocular Hypertension; Preservatives, Pharmaceutical; Prospective Studies; Quality of Life; Surveys and Questionnaires; Tears | 2013 |
Mucin deficiency causes functional and structural changes of the ocular surface.
Topics: Animals; Biopsy; DNA Primers; Dry Eye Syndromes; Eye; Eye Diseases; Fluorescein; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microsatellite Repeats; Mucin 5AC; Mucins; Mutation; Polymerase Chain Reaction; Tears | 2012 |
A novel fluorescent lipid probe for dry eye: retrieval by tear lipocalin in humans.
Topics: Chromatography, Ion Exchange; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Lipocalin 1; Male; Microscopy, Fluorescence; Tears | 2013 |
Lid-wiper epitheliopathy and dry-eye symptoms in contact lens wearers.
Topics: Adult; Conjunctival Diseases; Contact Lenses, Hydrophilic; Contrast Media; Dry Eye Syndromes; Epithelium; Eyelid Diseases; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Middle Aged; Prospective Studies; Rose Bengal | 2002 |
[Lacunar folds study in dry eye diagnosis].
Topics: Adult; Aged; Conjunctiva; Conjunctival Diseases; Contrast Media; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Prospective Studies | 2003 |
Correlation of lipid layer thickness measurements with fluorescein tear film break-up time and Schirmer's test.
Topics: Adult; Aged; Anesthesia, Local; Dry Eye Syndromes; Female; Fluorescein; Humans; Lipids; Male; Middle Aged; Reproducibility of Results; Tears | 2003 |
Gefarnate stimulates goblet cell repopulation following an experimental wound to the tarsal conjunctiva in the dry eye rabbit.
Topics: Animals; Cell Count; Cell Division; Conjunctiva; Contrast Media; Dry Eye Syndromes; Fluorescein; Fluorescent Dyes; Gefarnate; Goblet Cells; Male; Rabbits; Rose Bengal | 2002 |
Conjunctival characteristics of contact lens wearers and nonwearers and their association with symptomatology.
Topics: Adult; Chi-Square Distribution; Conjunctiva; Contact Lenses, Hydrophilic; Contrast Media; Dry Eye Syndromes; Female; Fluorescein; Humans; Lissamine Green Dyes; Male; Middle Aged; Reference Values; Staining and Labeling | 2002 |
Ocular sensations and symptoms associated with tear break up.
Topics: Contrast Media; Dry Eye Syndromes; Eye; Fluorescein; Humans; Reference Values; Sensation; Surveys and Questionnaires; Tears; Time Factors | 2002 |
Evaluation of the akorn dry eye test (DET) as a predictor of contact lens comfort.
Topics: Blinking; Contact Lenses; Contrast Media; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Eye; Fluorescein; Forecasting; Humans; Reagent Strips; Sensation; Surveys and Questionnaires; Tears | 2002 |
Efficacy of autologous serum treatment in patients with severe dry eye.
Topics: Aged; Biological Factors; Blood Physiological Phenomena; Contrast Media; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Middle Aged; Rose Bengal; Severity of Illness Index; Treatment Outcome | 2002 |
Silicon punctal plug insertion in the treatment of severe dry eye.
Topics: Aged; Contrast Media; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Middle Aged; Prosthesis Implantation; Rose Bengal; Silicon; Staining and Labeling; Treatment Outcome | 2002 |
The association of bulbar conjunctival folds with other clinical findings in normal and moderate dry eye subjects.
Topics: Adult; Aged; Aging; Case-Control Studies; Conjunctiva; Contrast Media; Cornea; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Osmolar Concentration; Staining and Labeling; Tears | 2003 |
Evaluation of the clinical course of dry eye syndrome.
Topics: Adult; Aged; Aged, 80 and over; Dry Eye Syndromes; Eyelid Diseases; Female; Fluorescein; Fluorescent Dyes; Follow-Up Studies; Humans; Male; Meibomian Glands; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Rose Bengal; Tears | 2003 |
A novel grading method for superficial punctate keratopathy magnitude and its correlation with corneal epithelial permeability.
Topics: Corneal Diseases; Dry Eye Syndromes; Epithelium, Corneal; Fluorescein; Fluorophotometry; Humans; Permeability | 2003 |
Dry eye signs and symptoms in women with premature ovarian failure.
Topics: Adolescent; Adult; Conjunctiva; Cornea; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Health Status Indicators; Humans; Lissamine Green Dyes; Primary Ovarian Insufficiency; Self Disclosure; Surveys and Questionnaires; Tears | 2004 |
The repeatability of clinical measurements of dry eye.
Topics: Adult; Aged; Aged, 80 and over; Conjunctiva; Cornea; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Eyelid Diseases; Female; Fluorescein; Humans; Lacrimal Apparatus; Male; Meibomian Glands; Middle Aged; Reproducibility of Results; Rose Bengal; Tears | 2004 |
Punctal occlusion in the management of chronic Stevens-Johnson syndrome.
Topics: Adolescent; Adult; Aged; Cautery; Child; Chronic Disease; Dry Eye Syndromes; Female; Fluorescein; Fluorophotometry; Humans; Lacrimal Apparatus; Male; Middle Aged; Prostheses and Implants; Retrospective Studies; Rose Bengal; Stevens-Johnson Syndrome; Tears; Visual Acuity | 2004 |
Tear function and ocular surface findings in premature and term babies.
Topics: Case-Control Studies; Conjunctival Diseases; Corneal Diseases; Dry Eye Syndromes; Female; Fluorescein; Fluorophotometry; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases; Lacrimal Apparatus Diseases; Male; Prospective Studies; Staining and Labeling; Tears | 2004 |
[A study of lacunar folds in relation to the etiology and severity of dry eye].
Topics: Conjunctiva; Conjunctival Diseases; Contrast Media; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Prospective Studies; Severity of Illness Index | 2004 |
A novel porcine dry eye model system (pDEM) with simulated lacrimation/blinking system: preliminary findings on system variability and effect of corneal drying.
Topics: Animals; Blinking; Coloring Agents; Cornea; Disease Models, Animal; Dry Eye Syndromes; Fluorescein; Lacrimal Apparatus; Swine; Trypan Blue | 2004 |
The lack of association between signs and symptoms in patients with dry eye disease.
Topics: Adult; Aged; Aged, 80 and over; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Eyelid Diseases; Female; Fluorescein; Health Status Indicators; Humans; Male; Meibomian Glands; Middle Aged; Reproducibility of Results; Rose Bengal; Staining and Labeling; Tears | 2004 |
Lid wiper epitheliopathy and dry eye symptoms.
Topics: Adult; Aged; Conjunctival Diseases; Contrast Media; Dry Eye Syndromes; Eyelids; Fluorescein; Fluorescent Dyes; Humans; Middle Aged; Prevalence; Rose Bengal; Staining and Labeling | 2005 |
Tear function in babies.
Topics: Conjunctival Diseases; Corneal Diseases; Dry Eye Syndromes; Fluorescein; Fluorophotometry; Humans; Infant, Newborn; Infant, Premature, Diseases; Lacrimal Apparatus Diseases; Staining and Labeling; Tears | 2005 |
Tear film dynamics in floppy eyelid syndrome.
Topics: Adult; Aged; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Eyelid Diseases; Female; Fluorescein; Humans; Kinetics; Lipids; Male; Middle Aged; Skin Temperature; Tears; Wettability | 2005 |
Tear film function and corneal sensation in the early postoperative period after LASEK for the correction of myopia.
Topics: Adult; Contrast Media; Cornea; Dry Eye Syndromes; Female; Fluorescein; Humans; Keratectomy, Subepithelial, Laser-Assisted; Male; Myopia; Postoperative Complications; Postoperative Period; Prospective Studies; Sensation; Staining and Labeling; Surveys and Questionnaires; Tears | 2005 |
The controlled-environment chamber: a new mouse model of dry eye.
Topics: Air; Animals; Atmosphere Exposure Chambers; Cell Count; Conjunctiva; Cornea; Disease Models, Animal; Dry Eye Syndromes; Environment, Controlled; Epithelial Cells; Female; Fluorescein; Goblet Cells; Humidity; Mice; Mice, Inbred BALB C; Staining and Labeling; Tears; Temperature | 2005 |
Evaluating an impression cytology grading system (IC score) in patients with dry eye syndrome.
Topics: Cytological Techniques; Diagnosis, Computer-Assisted; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Middle Aged | 2006 |
Lipid tear deficiency in persistent dry eye after laser in situ keratomileusis and treatment results of new eye-warming device.
Topics: Adult; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Fluorophotometry; Humans; Hypothermia, Induced; Keratomileusis, Laser In Situ; Lipids; Male; Middle Aged; Prospective Studies; Tears | 2005 |
Bulbar conjunctival staining in contact lens wearers and non lens wearers and its association with symptomatology.
Topics: Adult; Coloring Agents; Conjunctival Diseases; Contact Lenses, Hydrophilic; Dry Eye Syndromes; Female; Fluorescein; Humans; Lissamine Green Dyes; Male; Ophthalmic Solutions; Staining and Labeling | 2005 |
Atelocollagen punctal occlusion in dry eye patients.
Topics: Adult; Aged; Collagen; Dry Eye Syndromes; Epithelium, Corneal; Eyelids; Female; Fluorescein; Fluorescent Dyes; Fluorophotometry; Humans; Lacrimal Apparatus; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Rose Bengal; Tears; Treatment Outcome | 2006 |
Tear breakup dynamics: a technique for quantifying tear film instability.
Topics: Adult; Blinking; Contrast Media; Cornea; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Ophthalmic Solutions; Surveys and Questionnaires; Tears; Video Recording | 2006 |
Clinical evaluation of the Smart Plug in the treatment of dry eyes.
Topics: Dry Eye Syndromes; Fluorescein; Fluorescent Dyes; Humans; Lacrimal Apparatus; Prostheses and Implants; Prosthesis Implantation; Rose Bengal; Tears | 2006 |
Marx line: fluorescein staining line on the inner lid as indicator of meibomian gland function.
Topics: Adult; Dry Eye Syndromes; Eyelids; Female; Fluorescein; Fluorescent Dyes; Humans; Lissamine Green Dyes; Male; Meibomian Glands; Middle Aged; Prospective Studies; Rose Bengal; Staining and Labeling; Tears | 2006 |
Lid wiper epitheliopathy and dry eye symptoms.
Topics: Adult; Aged; Aged, 80 and over; Conjunctival Diseases; Contrast Media; Dry Eye Syndromes; Eyelids; Fluorescein; Fluorescent Dyes; Humans; Middle Aged; Rose Bengal; Staining and Labeling | 2006 |
Fluorophotometry as a diagnostic tool for the evaluation of dry eye disease.
Topics: Adult; Aged; Contrast Media; Cornea; Dry Eye Syndromes; Fluorescein; Fluorophotometry; Humans; Instillation, Drug; Middle Aged; Osmolar Concentration; Permeability; Pilot Projects; Time Factors | 2006 |
Desiccating stress stimulates expression of matrix metalloproteinases by the corneal epithelium.
Topics: Animals; Cornea; Desiccation; Disease Models, Animal; Dry Eye Syndromes; Epithelium, Corneal; Female; Fluorescein; Fluorescent Antibody Technique, Indirect; Male; Matrix Metalloproteinases; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Permeability; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Inhibitor of Metalloproteinases | 2006 |
Temporal progression and spatial repeatability of tear breakup.
Topics: Adult; Aged; Blinking; Case-Control Studies; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Middle Aged; Surveys and Questionnaires; Tears | 2006 |
Ophthalmic cyclosporine use in ocular GVHD.
Topics: Administration, Topical; Adolescent; Adult; Aged; Cyclosporine; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Fluorophotometry; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies | 2006 |
Delayed tear clearance in patients with conjunctivochalasis is associated with punctal occlusion.
Topics: Adult; Aged; Aged, 80 and over; Conjunctival Diseases; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Fluorophotometry; Humans; Lacrimal Duct Obstruction; Male; Middle Aged; Tears | 2007 |
Evaluation of ocular surface changes in a rabbit dry eye model using a modified impression cytology technique.
Topics: Animals; Conjunctiva; Cytological Techniques; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Fluorescein; Fluorescent Dyes; Goblet Cells; Microscopy, Electron; Microscopy, Electron, Scanning; Rabbits | 2007 |
Quantitative evaluation of tear meniscus height from fluorescein photographs.
Topics: Adolescent; Adult; Aged; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Fluorophotometry; Humans; Male; Middle Aged; Photography; Tears | 2007 |
Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome.
Topics: Administration, Topical; Adult; Case-Control Studies; Cell Count; Cornea; Dry Eye Syndromes; Female; Fetal Blood; Fluorescein; Goblet Cells; Humans; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Serum; Tears | 2007 |
Extended-wear silicone hydrogel soft contact lenses in the management of moderate to severe dry eye signs and symptoms secondary to graft-versus-host disease.
Topics: Adult; Aged; Contact Lenses, Extended-Wear; Contact Lenses, Hydrophilic; Cornea; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Graft vs Host Disease; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Male; Middle Aged; Prospective Studies; Silicones; Staining and Labeling; Surveys and Questionnaires; Tears; Treatment Outcome; Visual Acuity | 2007 |
The role of conjunctival epithelial cell xanthine oxidoreductase/xanthine oxidase in oxidative reactions on the ocular surface of dry eye patients with Sjögren's syndrome.
Topics: Adult; Conjunctiva; Dry Eye Syndromes; Epithelial Cells; Female; Fluorescein; Fluorescent Dyes; Histocytochemistry; Humans; Immunohistochemistry; Male; Middle Aged; Oxidation-Reduction; Severity of Illness Index; Sjogren's Syndrome; Tears; Xanthine Oxidase | 2007 |
SmartPlug in the management of severe dry eye syndrome.
Topics: Adult; Aged; Aged, 80 and over; Biocompatible Materials; Dry Eye Syndromes; Eyelids; Female; Fluorescein; Humans; Lacrimal Apparatus; Male; Middle Aged; Ophthalmologic Surgical Procedures; Postoperative Complications; Prostheses and Implants; Prosthesis Implantation; Retrospective Studies; Tears | 2007 |
Evaluation of novel dry eye model: preganglionic parasympathetic denervation in rabbit.
Topics: Animals; Autonomic Fibers, Preganglionic; Blinking; Cell Count; Disease Models, Animal; Dry Eye Syndromes; Fluorescein; Ganglia, Parasympathetic; Goblet Cells; Lacrimal Apparatus; Male; Parasympathectomy; Rabbits; Rose Bengal; Tears | 2007 |
An evaluation of the efficacy of fluorescein, rose bengal, lissamine green, and a new dye mixture for ocular surface staining.
Topics: Adult; Aged; Coloring Agents; Conjunctiva; Cornea; Dose-Response Relationship, Drug; Drug Combinations; Dry Eye Syndromes; Fluorescein; Humans; Lissamine Green Dyes; Middle Aged; Ophthalmic Solutions; Prospective Studies; Reproducibility of Results; Rose Bengal; Severity of Illness Index; Staining and Labeling | 2008 |
Topical omega-3 and omega-6 fatty acids for treatment of dry eye.
Topics: Administration, Topical; alpha-Linolenic Acid; Animals; CD11b Antigen; Cell Count; Conjunctiva; Cornea; Cytokines; Disease Models, Animal; Dry Eye Syndromes; Fluorescein; Fluorescent Antibody Technique, Indirect; Linoleic Acid; Mice; Mice, Inbred C57BL; Monocytes; Ophthalmic Solutions; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome | 2008 |
Documentation of corneal epithelial defects with fluorescein-enhanced digital fundus camera photography.
Topics: Diagnosis, Differential; Dry Eye Syndromes; Epithelium, Corneal; Fluorescein; Fluorescent Dyes; Fuchs' Endothelial Dystrophy; Humans; Image Processing, Computer-Assisted; Keratitis, Herpetic; Ophthalmic Solutions; Photography | 2008 |
Autologous serum in the management of recalcitrant dry eye syndrome.
Topics: Adult; Aged; Aged, 80 and over; Blood Proteins; Cornea; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Follow-Up Studies; Humans; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Serum; Treatment Outcome | 2008 |
Practical double vital staining for ocular surface evaluation.
Topics: Dry Eye Syndromes; Fluorescein; Fluoresceins; Humans; Rose Bengal; Staining and Labeling | 1993 |
Clinical evaluation of corneal epithelial barrier function with the slit-lamp fluorophotometer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Cornea; Dry Eye Syndromes; Epithelium; Evaluation Studies as Topic; Fluorescein; Fluoresceins; Fluorophotometry; Humans; Middle Aged; Permeability | 1995 |
Tear meniscus measurement in the diagnosis of dry eye.
Topics: Aged; Case-Control Studies; Coloring Agents; Dry Eye Syndromes; Evaluation Studies as Topic; Female; Fluorescein; Fluoresceins; Fluorescent Dyes; Humans; Male; Methods; Middle Aged; Phenolsulfonphthalein; Photography; Rose Bengal; Tears | 1996 |
Soluble interleukin-2 receptors and serum autoantibodies in dry eye patients: correlation with lacrimal gland function.
Topics: Antibodies, Antinuclear; Biomarkers; Dry Eye Syndromes; Enzyme-Linked Immunosorbent Assay; Female; Fluorescein; Fluoresceins; Fluorescent Dyes; Humans; Lacrimal Apparatus; Male; Middle Aged; Receptors, Interleukin-2; Retrospective Studies; Rheumatoid Factor; Rose Bengal; Solubility; Tears | 1997 |
Tear fluid plasmin activity of dry eye patients with Sjögren's syndrome.
Topics: Adult; Aged; Conjunctiva; Cornea; Dry Eye Syndromes; Female; Fibrinolysin; Fluorescein; Fluoresceins; Fluorescent Dyes; Fluorometry; Humans; Male; Middle Aged; Rose Bengal; Sjogren's Syndrome; Tears | 1997 |
Relationship between tear-meniscus parameters and tear-film breakup.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Blinking; Contrast Media; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Ophthalmic Solutions; Reproducibility of Results; Surface Tension; Tears; Video Recording | 1997 |
Diagnostic usefulness and cutoff value of Schirmer's I test in the Japanese diagnostic criteria of dry eye.
Topics: Adult; Aged; Contrast Media; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Japan; Male; Middle Aged; Reproducibility of Results; Rose Bengal; Sensitivity and Specificity; Surface Tension; Tears | 1997 |
The changes of tear break up time after myopic excimer laser photorefractive keratectomy.
Topics: Adult; Contrast Media; Cornea; Dry Eye Syndromes; Fluorescein; Follow-Up Studies; Humans; Lasers, Excimer; Myopia; Photorefractive Keratectomy; Retrospective Studies; Surface Tension; Tears; Visual Acuity | 1997 |
Evaluation of Schirmer tests by two types of tear clearance tests.
Topics: Adult; Diagnosis, Differential; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Humans; Lacrimal Apparatus; Middle Aged; Reproducibility of Results; Rose Bengal; Sjogren's Syndrome; Tears | 1998 |
Conjunctival epithelium expression of HLA-DR in dry eye patients.
Topics: Antibodies, Monoclonal; Conjunctiva; Contrast Media; Dry Eye Syndromes; Epithelium; Female; Flow Cytometry; Fluorescein; Fluorescent Antibody Technique; Fluorescent Dyes; HLA-DR Antigens; Humans; Intercellular Adhesion Molecule-1; Male; Middle Aged; Rose Bengal; Sjogren's Syndrome | 1999 |
Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms.
Topics: Adult; Case-Control Studies; Cornea; Dry Eye Syndromes; Eyelid Diseases; Fluorescein; Fluorophotometry; Humans; Meibomian Glands; Middle Aged; Predictive Value of Tests; Reproducibility of Results; Sensitivity and Specificity; Tears | 1999 |
Diseases associated with ocular surface abnormalities: the importance of reflex tearing.
Topics: Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Sjogren's Syndrome; Staining and Labeling; Tears | 1999 |
Corneal thickness is reduced in dry eye.
Topics: Adult; Aged; Aged, 80 and over; Aqueous Humor; Astigmatism; Contrast Media; Cornea; Corneal Topography; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Refraction, Ocular | 1999 |
A standardized visual scale for evaluation of tear fluorescein clearance.
Topics: Case-Control Studies; Conjunctiva; Cornea; Dry Eye Syndromes; Eyelid Diseases; Female; Fluorescein; Fluorophotometry; Humans; Male; Meibomian Glands; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Tears | 2000 |
Frequency of dry eye diagnostic test procedures used in various modes of ophthalmic practice.
Topics: Contrast Media; Cornea; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Humans; Male; Middle Aged; Ophthalmic Solutions; Ophthalmology; Retrospective Studies; Rose Bengal; Severity of Illness Index; Surface Properties; Tears | 2000 |
Survey of preferred tests for diagnosis of the tear film and dry eye.
Topics: Contrast Media; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Fluorescein; Fluorescent Dyes; Health Surveys; Humans; Ophthalmic Solutions; Ophthalmology; Optometry; Rose Bengal; Surface Properties; Surveys and Questionnaires; Tears | 2000 |
The height and radius of the tear meniscus and methods for examining these parameters.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Severity of Illness Index; Surface Properties; Tears; Video Recording | 2000 |
Prevalence of dry eye subtypes in clinical optometry practice.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Child; Child, Preschool; Contrast Media; Diagnosis, Differential; Dry Eye Syndromes; Female; Fluorescein; Humans; Male; Middle Aged; Ophthalmic Solutions; Prevalence; Prospective Studies; Queensland; Sex Distribution; Tears | 2000 |
Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model.
Topics: Animals; Biological Transport; Cornea; Dry Eye Syndromes; Fluorescein; Fluorophotometry; Goblet Cells; Male; Membrane Glycoproteins; Ophthalmic Solutions; Permeability; Polyphosphates; Purinergic P2 Receptor Agonists; Rats; Rats, Sprague-Dawley; Tears; Uracil Nucleotides | 2001 |
Effects of laser in situ keratomileusis on tear production, clearance, and the ocular surface.
Topics: Adult; Astigmatism; Conjunctival Diseases; Cornea; Corneal Diseases; Denervation; Dry Eye Syndromes; Female; Fluorescein; Fluorophotometry; Humans; Hypesthesia; Keratomileusis, Laser In Situ; Male; Middle Aged; Myopia; Ophthalmic Nerve; Prospective Studies; Surveys and Questionnaires; Tears; Touch; Visual Acuity | 2001 |
Reflex and steady state tears in patients with latent stromal herpetic keratitis.
Topics: Blinking; Corneal Stroma; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Fluorophotometry; Herpesvirus 1, Human; Humans; Keratitis, Herpetic; Lacrimal Apparatus; Male; Middle Aged; Tears | 2002 |
A comparison of the effect of refresh plus and bion tears on dry eye symptoms and ocular surface health in myopic LASIK patients.
Topics: Adult; Carboxymethylcellulose Sodium; Contrast Media; Dry Eye Syndromes; Eye; Female; Fluorescein; Health Status; Humans; Hypromellose Derivatives; Incidence; Keratomileusis, Laser In Situ; Male; Methylcellulose; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Staining and Labeling; Surface Properties; Treatment Outcome | 2002 |
Corneal epithelial permeability of dry eyes before and after treatment with artificial tears.
Topics: Benzalkonium Compounds; Cornea; Corneal Stroma; Dry Eye Syndromes; Epithelium; Fluorescein; Fluoresceins; Fluorophotometry; Humans; Middle Aged; Permeability; Povidone-Iodine | 1992 |
Effect of eledoisin on tear volume and tear flow in humans as assessed by fluorophotometry.
Topics: Administration, Topical; Adult; Conjunctiva; Dry Eye Syndromes; Eledoisin; Fluorescein; Fluoresceins; Fluorophotometry; Humans; Middle Aged; Secretory Rate; Tears | 1991 |
Measurement of the tear meniscus height using 0.25% fluorescein sodium.
Topics: Dry Eye Syndromes; Fluorescein; Fluoresceins; Humans; Tears | 1991 |
Tear film profile in dry eye.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Child; Child, Preschool; Dry Eye Syndromes; Female; Fluorescein; Fluoresceins; Humans; Hydrogen-Ion Concentration; Lissamine Green Dyes; Male; Middle Aged; Rose Bengal; Tears; Vision Tests | 1991 |
Influence of artificial tears on corneal epithelium in dry-eye syndrome.
Topics: Benzalkonium Compounds; Chlorobutanol; Cornea; Dry Eye Syndromes; Epithelium; Fluorescein; Fluoresceins; Humans; Ophthalmic Solutions; Permeability; Preservatives, Pharmaceutical | 1989 |